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Abstract 
 Computational protein design determines the amino acid sequence(s) that 
will adopt a desired fold.  It allows the sampling of a large sequence space in a 
short amount of time compared to experimental methods.  Computational protein 
design tests our understanding of the physical basis of a protein’s structure and 
function, and over the past decade, has proven to be an effective tool. 
 We report the diverse applications of computational protein design with 
ORBIT (Optimization of Rotamers by Iterative Techniques).  We successfully 
utilized ORBIT to construct a reagentless biosensor for nonpolar ligands on the 
maize non-specific lipid transfer protein, by first removing native disulfide bridges.  
We identified an important residue position capable of modulating the agonist 
specificity of the mouse muscle nicotinic acetylcholine receptor (nAChR) for its 
agonists: acetylcholine, nicotine, and epibatidine.  Our efforts on enzyme design 
produced a lysozyme mutant with ester hydrolysis activity, while progress was 
made toward the design of a novel aldolase.   
Computational protein design has proven to be a powerful tool for the 
development of novel and improved proteins.  As we gain a better understanding 
of proteins and their functions, protein design will find many more exciting 
applications. 
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Chapter 1 
 
Introduction 
 
1
Protein Design 
 While it remains nontrivial to predict the three-dimensional structure a 
linear sequence of amino acids will adopt in its native state, much progress has 
been made in the field of protein folding due to major enhancements in 
computing power and the development of new algorithms.  The inverse of the 
protein folding problem, the protein design problem, has benefited from the same 
advances.  Protein design determines the amino acid sequence(s) that will adopt 
a desired fold.  Historically, proteins have been designed by applying rules 
observed from natural proteins, or by employing selection and evolution 
experiments in which a particular function is used to separate the desired 
sequences from the pool of largely undesirable sequences. Computational 
methods have also been used to model proteins and obtain an optimal sequence, 
the figurative “needle in the haystack.”  Computational protein design has the 
advantage of sampling much larger sequence space in a shorter amount of time 
compared to experimental methods.  Lastly, the computational approach tests 
our understanding of the physical basis of a protein’s structure and function, and 
over the past decade, has proven to be an effective tool in protein design.  
 
Computational Protein Design with ORBIT 
Computational protein design has three basic requirements: knowledge of 
the forces that stabilize the folded state of a protein relative to the unfolded state, 
a forcefield that accurately captures these interactions, and an efficient 
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optimization algorithm.  ORBIT (Optimization of Rotamers by Iterative 
Techniques) is a protein design software package developed by the Mayo lab.  It 
takes as input a high-resolution structure of the desired fold, and outputs the 
amino acid sequence(s) that are predicted to adopt the fold.  If available, high-
resolution crystal structures of proteins are often used for design calculations, 
although NMR structures, homology models, and even novel folds can be used.  
A design calculation is then defined to specify the residue positions and residue 
types to be sampled.  A library of discrete amino acid conformations, or rotamers, 
are then modeled at each position and pair-wise interaction energies are 
calculated using an energy function based on the atom-based DREIDING 
forcefield.1  The forcefield includes terms for van der Waals interactions, 
hydrogen bonds, electrostatics, and the interaction of the amino acids with 
water.2-4  Combinatorial optimization algorithms such as Monte Carlo and 
algorithms based on the dead-end elimination theorem are then used to 
determine the global minimum energy conformation (GMEC) or sequences near 
the GMEC.5-8  The sequences can be experimentally tested to determine the 
accuracy of the design calculation.  Protein stability and function require a 
delicate balance of contributing interactions; the closer the energy function gets 
toward achieving the proper balance, the higher the probability the sequence will 
adopt the desired fold and function.  By utilizing the “design cycle” that iterates 
from theory to computation to experiment, improvements in the energy function 
can be continually made, leading to better designed proteins.  
3
The Mayo lab has successfully utilized the design cycle to improve the 
energy function, and developments in combinatorial optimization algorithms 
allowed ever-larger design calculations.  Consequently, both novel and improved 
proteins have been designed.  The β1 domain of protein G and engrailed 
homeodomain from Drosophila have been designed with greatly increased 
thermostability compared to their wild-type sequences.9, 10  Full sequence designs 
have generated a 28-residue zinc finger that does not require zinc to maintain its 
three-dimensional fold3 and an engrailed homeodomain variant that is 80% 
different from the wild-type sequence yet still retains its fold.11  
 
Applications of Computational Protein Design 
Generating proteins with increased stability is one application of protein 
design.  Other potential applications include improving the catalysis of existing 
enzymes, modifying or generating binding specificity for ligands, substrates, 
peptides, and other proteins, and generating novel proteins and enzymes.  New 
methods continue to be created for protein design to support an ever-wider range 
of applications.  My work has been on the application of computational protein 
design by ORBIT. 
In chapters 2 and 3, we used protein design to remove disulfide bridges 
from maize non-specific lipid-transfer protein (mLTP).  By coupling the resulting 
conformational flexibility with an environment sensitive fluorescent probe, we 
generated a reagentless biosensor for nonpolar ligands.   
4
Chapter 4 is an extension of previous work by Bolon and Mayo12 that 
generated the first computationally designed enzyme, PZD2, an ester hydrolase.  
We first probed the effect of four anionic residues (near the catalytic site) on the 
catalytic rate of PZD2.  Separately, we engineered ester hydrolysis activity into 
T4 lysozyme, demonstrating the general applicability of the “compute and build” 
method utilized for PZD2. 
The same method was applied to generate an enzyme to catalyze the 
aldol reaction, a carbon-carbon bond-making reaction that is more difficult to 
catalyze than ester hydrolysis. Chapter 5 details the efforts toward the design of 
a novel aldolase.  
Chapter 6 describes the double mutant cycle study of a cation-π 
interaction to ascertain its interaction energy.  We used protein design to 
determine the optimal sites for incorporation of the amino acid pair.  
In chapter 7, we utilized computational protein design to identify a 
mutation that modulated the agonist specificity of the nicotinic acetylcholine 
receptor (nAchR) for its agonists, acetylcholine, nicotine, and epibatidine.  
 We have shown diverse applications of computational protein design.  
From the first notable success in 1997, the field has advanced quickly.  Other 
recent advances in protein design include the full sequence design of a protein 
with a novel fold13 and dramatic increases in binding specificity of proteins.14, 15  
Hellinga and co-workers achieved nanomolar binding affinity of a designed 
protein for its non-biological ligands16 and built a family of biosensors for small 
5
polar ligands from the same family of proteins.17-19  They also used a combination 
of protein design and directed evolution experiments to generate triosephosphate 
isomerase (TIM) activity in ribose binding protein.20   
Computational protein design has proven to be a powerful tool.  It has 
demonstrated its effectiveness in generating novel and improved proteins.  As we 
gain a better understanding of proteins and their functions, protein design will find 
many more exciting applications.  
 
6
References 
1. Mayo, S. L., Olafson, B. D. & Goddard III, W. A. DREIDING: A generic 
force field for molecular simulations. Journal of Physical Chemistry 94, 
8897-8909 (1990). 
2. Gordon, D. B., Marshall, S. A. & Mayo, S. L. Energy functions for protein 
design. Curr Opin Struct Biol 9, 509-13 (1999). 
3. Dahiyat, B. I. & Mayo, S. L. Probing the role of packing specificity in 
protein design. Proceedings of the Natational Academy of Sciences of the 
United States of America 94, 10172-7. (1997). 
4. Street, A. G. & Mayo, S. L. Pairwise calculation of protein solvent -
accessible surface areas. Folding & Design 3, 253-258 (1998). 
5. Gordon, D. B. & Mayo, S. L. Radical performance enhancements for 
combinatorial optimization algorithms based on the dead-end elimination 
theorem. J Comp Chem 19, 1505-1514 (1998). 
6. Gordon, D. B. & Mayo, S. L. Branch-and-Terminate: a combinatorial 
optimization algorithm for protein design. Structure Fold Des 7, 1089-1098 
(1999). 
7. Pierce, N. A., Spriet, J. A., Desmet, J. & Mayo, S. L. Conformational 
splitting:  a more powerful criterion for dead-end elimination. J Comp 
Chem 21, 999-1009 (2000). 
7
8. Voigt, C. A., Gordon, D. B. & Mayo, S. L. Trading accuracy for speed: a 
quantitative comparison of search algorithms in protein sequence design. 
J Mol Biol 299, 789-803 (2000). 
9. Malakauskas, S. M. & Mayo, S. L. Design, structure and stability of a 
hyperthermophilic protein variant. Nature Struct Biol 5, 470-475 (1998). 
10. Marshall, S. A. & Mayo, S. L. Achieving stability and conformational 
specificity in designed proteins via binary patterning. J Mol Biol 305, 619-
31. (2001). 
11. Shah, P. S. (California Institute of Technology, Pasadena, CA, 2005). 
12. Bolon, D. N. & Mayo, S. L. Enzyme-like proteins by computational design. 
Proc Natl Acad Sci U S A 98, 14274-9. (2001). 
13. Kuhlman, B. et al. Design of a Novel Globular Protein Fold with Atomic-
Level Accuracy. Science 302, 1364-1368 (2003). 
14. Kortemme, T. et al. Computational redesign of protein-protein interaction 
specificity. Nat Struct Mol Biol 11, 371-9 (2004). 
15. Shifman, J. M. & Mayo, S. L. Exploring the origins of binding specificity 
through the computational redesign of calmodulin. Proc Natl Acad Sci U S 
A 100, 13274-9 (2003). 
16. Looger, L. L., Dwyer, M. A., Smith, J. J. & Hellinga, H. W. Computational 
design of receptor and sensor proteins with novel functions. Nature 423, 
185-90 (2003). 
8
17. Marvin, J. S. & Hellinga, H. W. Engineering Biosensors by Introducing 
Fluorescent Allosteric Signal Transducers: Construction of a Novel 
Glucose Sensor. J. Am. Chem. Soc. 120, 7-11 (1998). 
18. De Lorimier, R. M. et al. Construction of a fluorescent biosensor family. 
Protein Sci 11, 2655-2675 (2002). 
19. Marvin, J. S. et al. The rational design of allosteric interactions in a 
monomeric protein and its applications to the construction†of†biosensors. 
PNAS 94, 4366-4371 (1997). 
20. Dwyer, M. A., Looger, L. L. & Hellinga, H. W. Computational design of a 
biologically active enzyme. Science 304, 1967-71 (2004). 
 
 
9
 
 
 
Chapter 2 
 
Removal of Disulfide Bridges by  
Computational Protein Design 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adapted from manuscript in preparation by Jessica Mao,  Eun Jung Choi and 
Stephen L. Mayo.  To be submitted. 
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Introduction 
 One of the most common posttranslational modifications to extracellular 
proteins is the disulfide bridge, the covalent bond between two cysteine residues. 
Disulfide bridges are present in various protein classes and are highly conserved 
among proteins of related structure and function.1, 2  They perform multiple 
functions in proteins. They add stability to the folded protein3-5 and are important 
for protein structure and function.  Reduction of the disulfide bridges in some 
enzymes leads to inactivation.6, 7 
 Two general methods have been used to study the effect of disulfide 
bridges on proteins: the removal of native disulfide bonds and the insertion of 
novel ones.  Protein engineering studies to enhance protein stability by adding 
disulfide bridges have had mixed results.8  Addition of individual disulfides in T4 
lysozyme resulted in various mutants with raised or lowered Tm, a measure of 
protein stability.9, 10  Removal of disulfide bridges led to severely destabilized 
Conotoxin11 and produced RNase A mutants with lowered stability and activity.12, 
13   
Typically, mutations to remove disulfide bridges have substituted Cys with 
Ala, Ser or Thr, depending on the solvent accessibility of the native Cys. 
However, these mutations do not consider the protein background of the disulfide 
bridge.  For example, Cys to Ala mutations could destabilize the native state by 
creating cavities.  Computational protein design could allow us to compensate for 
the loss of stability by substituting stabilizing non-covalent interactions.  The 
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protein design software suite ORBIT (Optimization of Rotamers by Iterative 
Techniques)14 has been very successful in designing stable proteins,15, 16 and can 
predict mutations that would stabilize the native state without the disulfide bridge. 
 In this paper, we utilized ORBIT to computationally design out disulfide 
bridges in the non-specific lipid-transfer protein (ns-LTP) from maize (mLTP).  
mLTP is a 93-residue basic α-helical protein containing four disulfide bridges that 
are strictly conserved in the plant ns-LTP family.17-19 The ns-LTPs bind various 
polar lipids, fatty acids, acyl-coenzyme A,18 and they are proposed to defend the 
plant against bacterial and fungal pathogens.20  The high resolution crystal 
structure of mLTP17 makes it a good candidate for computational protein design.  
Our goal was to computationally remove the disulfide bridges and experimentally 
determine the effects on mLTP’s stability and ligand-binding activity. 
 
Materials and Methods 
Computational Protein Design 
The crystal structure of mLTP with palmitate (PDB ID 1MZM) was briefly 
energy minimized and its residues were classified as surface, boundary, or core 
based on solvent accessibility.21  Each of the four disulfide bridges were 
individually reduced by deletion of the S-S bond and addition of hydrogens.  The 
corresponding structures were used in designs for the respective disulfide bridge.  
The ORBIT protein design suite uses an energy function based on the 
DREIDING force field,22 which includes a Lennard-Jones 12-6 potential with all 
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van der Waals radii scaled by 0.9,23 hydrogen bonding and electrostatic terms 24 
and a solvation potential.   
Both solvent-accessible surface area-based solvation25 and the implicit 
solvation model developed by Lazaridis and Karplus26 were tried, but better 
results were obtained with the Lazaridis-Karplus model, and it was used in all 
final designs.  Polar burial energy was scaled by 0.6, and rotamer probability was 
scaled by 0.3, as suggested by Oscar Alvizo from fixed composition work with 
Engrailed homeodomain (unpublished data).  Parameters from the Charmm19 
force field were used.  An algorithm based on the dead-end elimination theorem 
(DEE) was used to obtain the global minimum energy amino acid sequence and 
conformation (GMEC).27 
For each design, non-Pro, non-Gly residues within 4 Å of the two reduced 
Cys were included as the 1st shell of residues and were designed; that is, their 
amino acid identities and conformations were optimized by the algorithm.  
Residues within 4 Å of the designed residues were considered the 2nd shell; 
these residues were floated, that is, their conformations were allowed to change, 
but their amino acid identities were held fixed.  Finally, the remaining residues 
were treated as fixed.  Based on the results of these design calculations, further 
restricted designs were carried out where only modeled positions making 
stabilizing interactions were included. 
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Protein Expression and Purification 
The Escherichia coli expression optimized gene encoding the mLTP 
amino acid sequence was synthesized and ligated into the pET15b vector 
(Stratagene) by Blue Heron Biotechnology (www.blueheronbio.com). The 
pET15b vector includes an N-terminal His-tag.  Inverse PCR mutagenesis was 
used to construct five variants, C4H/C52A/N55E, C4Q/C52A/N55S, C14A/C29S, 
C30A/C75A, and C50A/C89E.  The proteins were expressed in BL21(DE3) Gold 
cells (Stratagene) at 37 °C after induction with IPTG (isopropyl-beta-D-
thiogalactopyranoside).  The proteins expressed in the soluble fraction.  Cells 
were resuspended in lysis buffer (50 mM sodium phosphate, 300 mM sodium 
chloride, 10 mM imidazole, pH 8.0) and lysed by passing through the Emulsiflex 
at 15,000 psi, and the soluble fraction was obtained by centrifuge at 20,000g for 
30 minutes.  Protein purification was a two step process.  First, the soluble 
fraction of the cell lysate was loaded onto a Ni-NTA column and eluted with 
elution buffer (lysis buffer with 400 mM imidazole). The elutions were further 
purified by gel filtration with phosphate buffer (50 mM sodium phosphate, 150 
mM sodium chloride, pH 7.5).  Purified proteins were verified by SDS-Page and 
MALDI-TOF to be of sufficient purity and corresponded to the oxidized form of 
the proteins.  The N-terminal His-tags are present, without the N-terminal Met, as 
was confirmed by trypsin digests.  Protein concentration was determined using 
the BCA assay (Pierce) with BSA as the standard. 
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Circular Dichroism  
Circular dichroism (CD) data were obtained on an Aviv 62A DS 
spectropolarimeter equipped with a thermoelectric cell-holder.  Wavelength scans 
and thermal denaturation data were obtained from samples containing 50 μM 
protein.  For wavelength scans, data were collected every 1 nm from 200 to 250 
nm with averaging time of 5 seconds.  For thermal studies, data were collected 
every 2 °C from 1 °C to 99 °C using an equilibration time of 120 seconds and an 
averaging time of 30 seconds.  As the thermal denaturations were not reversible, 
we could not fit the data to a two-state transition.  The apparent Tms were 
obtained from the inflection point of the data.  For thermal denaturations of 
protein with palmitate, 150 μM palmitate was added to 50 μM protein from stock 
solution of >30 mM palmitate in ethanol (Sigma Aldrich). 
 
Results and Discussion 
mLTP Designs 
mLTP contains four disulfide bridges: C4-C52, C14-C29, C30-C75, and 
C50-C89, and we used the ORBIT protein design suite to design variants with the 
removal of each disulfide bridge. Calculations were evaluated and five variants 
were chosen, C4H/C52A/N55E, C4Q/C52A/N55S, C14A/C29S, C30A/C75A, and 
C50A/C89E (Figure 2-1).  For disulfide bridge C4-C52, the disulfide anchors two 
helices to each other, with C52 more buried than C4. In the final designs 
C4H/C52A/N55E and C4Q/C52A/N55S, the disulfide bridge is lost but residue 4 
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and 55 form an interhelical hydrogen bond, 4H-55E and 4Q-55S, with heavy 
atom distances of 2.8 Å.  C14A/C29S gains a hydrogen bond between S29 and 
S26.  For C30-C75, nonpolar residues surround the buried disulfide, and both 
residues are mutated to Ala.  C50-C89 anchors the C-terminal loop to helix 3.  
The mutation of C89E breaks the disulfide bridge but adds in hydrogen bonds 
with R47, S90 and K54, and C50 is mutated to Ala. 
 
Experimental Validation 
The circular dichroism wavelength scans of mLTP and the variants (Figure 
2-2) show three of the five variants (C4H/C52A/N55E, C4Q/C52A/N55S and 
C50A/C89E) are folded like the wild-type protein, with minimums at 208nm and 
222nm, characteristic of helical proteins.  C14A/C29S and C30A/C75A are not 
folded properly, with wavelength scans resembling those of ns-LTP with 
scrambled disulfides.28  Interestingly, both C14-C29 and C30-C75 are the more 
buried of the four disulfides, and are in close proximity to each other. 
Of the folded proteins, the gel filtration profile looked similar to that of wild-
type mLTP, which we verified to be a monomer by analytical ultracentrifugation 
(data not shown).  We determined the thermal stability of the variants in the 
absence and presence of palmitate and compared it to wild-type mLTP (Figure 2-
3).  The removal of the disulfide bridge C4-C52 significantly destabilized the 
protein relative to wild type, lowering the apparent Tms by as much as 28 °C 
(Table 2-1).  Disruption of C50-C89 led to only 10 °C lower apparent Tm.  The 
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variants are still able to bind palmitate, as thermal denaturations in the presence 
of palmitate raised the apparent melting temperatures as it does for the wild-type 
protein.   
For the C4-C52 mutants, C4H/C52A/N55E and C4Q/C52A/N55S behaved 
similarly, as each variant supplied one potential hydrogen bond to replace the S-
S covalent bond.  Upon binding palmitate, however, there is a much larger gain in 
stability than is observed for the wild-type protein; the Tms vary by as much as 20 
°C compared to only 8 °C for wild type.  The difference in apparent Tms for the 
palmitate bound mutants and wild-type is ~18 °C, 10 °C lower than the 28 °C 
difference observed for unbound protein.  A plausible explanation for the 
observed difference could be a conformational change between the unbound and 
bound forms.  In the unbound form, the disulfide that anchored the two helices to 
each other is no longer present, making the N-terminal helix more entropic, 
causing the protein to be less compact and lose stability.  But once palmitate is 
bound, the helix is brought back to desolvate the palmitate and returns to its 
compact globular shape.   
It is interesting that C50A/C89E is ~20 °C more stable than the C4-C52 
variants.  The disulfide C50-C89 anchors the long C-terminal loop to helix 3.  
Disruption of this disulfide only lowered the Tm by 10 °C.  This could be due to the 
three introduced hydrogen bonds that were a direct result of the C89E mutation.  
The stability gained by palmitate binding only raises the Tm by 6 °C, similar to the 
8 °C observed for wild-type mLTP.  For wild-type mLTP, the crystal and solution 
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structures show little change in conformation upon ligand binding,17, 18 and we 
suspect this to be the case for C50A/C89E. 
We have successfully used computational protein design to remove 
disulfide bridges in mLTP and experimentally determined its effect on protein 
stability and ligand binding.  Not surprisingly, the removal of the disulfide bridges 
destabilized mLTP.  We determined two of the four disulfide bridges could be 
removed individually and the designed variants appear to retain their tertiary 
structure as they are still able to bind palmitate.  The C50A/C89E design with 
three compensating hydrogen bonds was the least destabilized, while 
C4H/C52A/N55E and C4Q/C52A/N55S appeared to show greater conformational 
change upon ligand binding.   
 
Future Directions 
The C4-C52 variants are promising as the basis for the development of a 
reagentless biosensor.  Fluorescent sensors are extremely sensitive to their 
environment, by conjugating a sensor molecule to the site of conformational 
change, the change in sensor signal could be a reporter for ligand binding.  
Hellinga and co-workers had constructed a family of biosensors for small, polar 
molecules using the periplasmic binding proteins,29 but a complementary system 
for nonpolar molecules has not been developed.  Given the nonspecific nature of 
mLTP ligand binding, mLTP could be engineered to be a reagentless biosensor 
for small nonpolar molecules.   
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Figure 2-1.  Ribbon diagram of mLTP and the designed variants of each 
disulfide.  The palmitate bound mLTP (cyan) is superimposed on the unbound 
protein (green).  Palmitate is shown in spheres with carbon in magenta and 
oxygen in red.  Disulfides are in orange.  In panels, mutated residues and the 
residues they form hydrogen bonds with are shown in stick with CPK-inspired 
colors, and the modeled hydrogen bonds are shown with yellow dashed lines, 
with measured heavy atom distances between 2.8 and 3.0 Å.  
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Figure 2-2.  Wavelength scans of mLTP and designed variants.  Variants 
C4H/C52A/N55E and C4Q/C52A/N55S and C50A/C89E are folded similar to 
wild-type mLTP, with minimums at 208nm and 222nm, but C14A/C29S and 
C30A/C75A are misfolded. 
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Figure 2-3.  Thermal denaturations of mLTP and designed variants: mLTP 
(red), C4H/C52A/N55E (blue), C4Q/C52A/N55S (green), and C50A/C89E (cyan).  
Solid lines are protein alone, dashed lines are protein with palmitate added.  
Removal of disulfide bridges significantly destabilized the protein, but the variants 
still bound palmitate.  
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       Table 2-1.  Apparent Tms of mLTP and designed variants. 
 
Apparent Tm 
 
Protein alone 
Protein + 
palmitate 
ΔTm 
mLTP 84 92 8 
C4H/C52A/N55E 56 76 20 
C4Q/C52A/N55S 56 74 18 
C50A/C89E 74 80 6 
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Chapter 3 
 
Engineering a Reagentless Biosensor  
for Nonpolar Ligands 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adapted from manuscript in preparation by Jessica Mao, Eun Jung Choi and 
Stephen L. Mayo.  To be submitted. 
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Introduction 
Recently there has been interest in using proteins as carriers for drugs 
due to their high affinity and selectivity for their targets.1 The proteins would not 
only protect the unstable or harmful molecules from oxidation and degradation, 
they would also aid in solubilization and ensure a controlled release of the 
agents.  Advances in genetic and chemical modifications on proteins have made 
it easier to engineer proteins for specific use.  Non-specific lipid transfer proteins 
(ns-LTP) from plants are a family of proteins that are of interest as potential 
carriers for nonpolar ligands for drug delivery.2, 3  The two classes of LTPs (LTP1 
and LTP2) share eight conserved cysteines that form four disulfide bridges and 
both have large nonpolar binding pockets.4-6  The ns-LTP1 bind various polar 
lipids, fatty acids and acyl-coenzyme A5 while ns-LTP2 bind bulkier sterol 
molecules.7 
In a study to determine the suitability of ns-LTPs as drug carriers, the 
intrinsic tyrosine fluorescence of wheat ns-LTP1 (wLTP) was monitored, and 
wLTP was found to bind to BD56, an antitumoral and antileishmania drug, and 
amphotericin B, an antifungal drug.3  However, this method is not very sensitive, 
as there are only two tyrosines in wLTP.  Cheng et al. virtually screened over 
7000 compounds for potential binding to maize ns-LTP1.2  A reliable, sensitive, 
high throughput method to screen for binding of the drug compounds to mLTP is 
still necessary to test the potential of mLTP as drug carriers against known drug 
molecules.  
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Gilardi and co-workers engineered the maltose binding protein for 
reagentless fluorescence sensing of maltose binding;9 their work was 
subsequently extended to construct a family of fluorescent biosensors from 
periplasmic binding proteins.  By conjugating various fluorophores to the family of 
proteins, Hellinga and co-workers were able to construct nanomolar to millimolar 
sensors for ligands including sugars, amino acids, anions, cations, and 
dipeptides.10-12 
Here we extend our previous work on the removal of disulfide bridges on 
mLTP, and report the engineering of mLTP as a reagentless biosensor for 
nonpolar ligands by conjugation with acrylodan, a thiol-reactive fluorescent 
probe. 
 
Materials and Methods 
Protein Expression, Purification and Acrylodan Labeling 
The Escherichia coli expression optimized gene encoding the mLTP 
amino acid sequence was synthesized and ligated into the pET15b vector 
(Stratagene) by Blue Heron Biotechnology (www.blueheronbio.com).  The 
pET15b vector includes an N-terminal His-tag.  Inverse PCR mutagenesis was 
used to construct four variants: C52A, C4H/N55E, C50A, and C89E.  The 
proteins were expressed in BL21(DE3) Gold cells (Stratagene) at 37 °C after 
induction with IPTG (isopropyl-beta-D-thiogalactopyranoside).  The proteins 
expressed in the soluble fraction.  Cells were resuspended in lysis buffer (50 mM 
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sodium phosphate, 300 mM sodium chloride, 10 mM imidazole, pH 8.0) and 
lysed by passing through the Emulsiflex at 15,000 psi, and the soluble fraction 
was obtained by centrifuging at 20,000g for 30 minutes.  Protein purification was 
a two step process.  First, the soluble fraction of the cell lysate was loaded onto a 
Ni-NTA column, eluted with elution buffer (lysis buffer with 400 mM imidazole), 
and concentrated to 10-20 µM. 6-acryloyl-2-(dimethylamino)naphthalene 
(acrylodan) was dissolved in acetonitrile and added to the elutions in 10-fold 
excess concentration, and the solution was incubated at 4 °C overnight.  All 
solutions containing acrylodan were protected from light.  Precipitated acrylodan 
and protein were removed by centrifugation and filtering through 0.2 µm nylon 
membrane Acrodisc syringe filters (Gelman Laboratory) and the soluble fraction 
was concentrated.  Unreacted acrylodan and protein impurities were removed by 
gel filtration with phosphate buffer (50 mM sodium phosphate, 150 mM sodium 
chloride, pH 7.5), simultaneously monitoring at 280 nm for protein and 391 nm for 
acrylodan.  The peak with both 280 nm and 391 nm absorbance was collected.  
The conjugation reaction looked to be complete, as both absorbances 
overlapped.  Purified proteins were verified by SDS-Page to be of sufficient 
purity, and MALDI-TOF showed that they correspond to the oxidized form of the 
proteins with acrylodan conjugated.  Protein concentration was determined with 
the BCA assay with BSA as the protein standard (Pierce). 
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Circular Dichroism Spectroscopy 
Circular dichroism (CD) data were obtained on an Aviv 62A DS 
spectropolarimeter equipped with a thermoelectric cell-holder.  Wavelength scans 
and thermal denaturation data were obtained from samples containing 50 μM 
protein.  For wavelength scans, data were collected every 1 nm from 250 to 200 
nm with an averaging time of 5 seconds at 25°C.  For thermal studies, data were 
collected every 2 °C, from 1°C to 99°C, using an equilibration time of 120 
seconds and an averaging time of 30 seconds.  As the thermal denaturations 
were not reversible, we could not fit the data to a two-state transition.  The 
apparent Tms were obtained from the inflection point of the data.  For thermal 
denaturations of protein with palmitate, 150 μM palmitate was added to 50 μM 
protein from stock solution of > 30 mM palmitate in ethanol (Sigma Aldrich). 
 
Fluorescence Emission Scan and Ligand Binding Assay 
 Ligand binding was monitored by observing the fluorescence emission of 
protein-acrylodan conjugates with the addition of palmitate.  Fluorescence was 
performed on a Photon Technology International Fluorometer equipped with 
stirrer at room temperature.  Excitation was set to 363 nm and emission was 
followed from 400 to 600 nm at 2 nm intervals and 0.5 second integration time.  
The average of three consecutive scans were taken.  2 ml of 500 nM protein-
acrylodan conjugate was used, and sodium palmitate (100uM) was titrated in.   
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Curve Fitting 
The dissociation constants (Kd) were determined by fitting the decrease in 
fluorescence with the addition of palmitate to equation (3-1) assuming one 
binding site.  The concentration of the protein-ligand complex (PL) is expressed 
in terms of Kd, total protein (P0) and ligand (L0) concentrations in equation (3-2). 
! 
F = F 0(P 0 " [PL]) + F max[PL]   (3-1) 
 
! 
[PL] =
(P 0 + Kd + L 0) " (P 0 + Kd + L 0)2 " 4 *P 0 *L 0
2
  (3-2) 
 
Results  
Protein-Acrylodan Conjugates 
 Previously, we had successfully expressed mLTP recombinantly in 
Escherichia coli.  Our work using computational design to remove disulfide 
bridges resulted in stable mLTP variants in which the disulfide bridges C4-C52 
and C50-C89 were removed individually (Figure 3-1).  The variants are less 
stable than wild-type mLTP, but still bind to palmitate, a natural ligand.  The 
removal of the disulfide bond could make the protein more flexible, and we 
coupled the conformational change with a detectable probe to develop a 
reagentless biosensor.  
We chose two of the variants, C4H/C52A/N55E and C50A/C89E, and 
mutated one of the original Cys residues in each variant back.  This gave us four 
new variants; C52A, C4H/N55E, C50A, and C89E. We conjugated acrylodan, an 
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environment sensitive thiol-reactive fluorophore13 to the resulting free Cys in each 
protein.  Trypsin digest and tandem mass spectrometry of the C52A-acrylodan 
complex (C52A/4C-Ac) confirmed the conjugation of acrylodan on Cys4.  Figure 
3-2 illustrates the site of acrylodan conjugation on C52A.  The sulfur atom of 
Cys4 that forms a covalent bond with acrylodan is ~ 14 Å away from the closest 
carbon atom on palmitate. 
We obtained the circular dichroism wavelength scans of the protein-
acrylodan conjugates to ensure they were properly folded (Figure 3-3).  While all 
four conjugates appeared folded, with characteristic helical protein minimums 
near 208nm and 222nm, only C52A/4C-Ac was most like wild-type mLTP.   
 
Fluorescence of Protein-Acrylodan Conjugates 
The fluorescence emission scans of the protein-acrylodan conjugates are 
varied in intensity and position of λmax.  C50A/89C-Ac, with acrylodan on the free 
Cys at residue 89, is the most shifted, with peak at 444 nm.  C89E/50C-Ac, with 
acrylodan on the more buried C50, has λmax at 464 nm.  For the C4-C52 pair, 
conjugating acrylodan to the more solvent exposed C4 for C52A/4C-Ac results in 
a peak at 456 nm, while conjugating to the more buried C52 for C4H/N55E/52C-
Ac gives a peak at 476 nm.  In both C4-C52 and C50-C89, acrylodan in the more 
buried positions on the protein caused the spectra to be blue shifted compared to 
its more exposed partners (Figure 3-4). 
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Ligand Binding Assays 
We performed titrations of the protein-acrylodan conjugates with palmitate 
to test the ability of the engineered mLTPs to act as biosensors.  Of the four 
protein-acrylodan conjugates, C52A/C4-Ac seemed to show the most marked 
difference in signal when palmitate is added.  The fluorescence of C52A/4C-Ac 
decreased as palmitate is titrated in (Figure 3-5a).  The fluorescence emission 
maximum at 476nm was used to fit a single site binding equation.  We 
determined the Kd to be 70 nM (Figure 3-5b).   
To verify the observed fluorescence change was due to palmitate binding, 
we assayed for binding by comparing the thermal denaturations of C52A/4C-Ac 
alone, and with palmitate.  We observed a change in apparent Tm from 59 ºC to 
66 ºC as palmitate is added to the protein-acrlodan conjugate (Figure 3-6).  The 
difference of 7 ºC is similar to the 8 ºC observed in apparent Tm increase for 
wild-type mLTP.   
 
Discussion 
We have successfully engineered mLTP into a fluorescent reagentless 
biosensor for nonpolar ligands. We believe the change in acrylodan signal is a 
measure of the local conformational change the protein variants undergo upon 
ligand binding.  The conjugation site for acrylodan is on the surface of the protein, 
away from the binding pocket (Figure 3-7).  It is possible that acrylodan, being a 
hydrophobic molecule, occupies the binding pocket of mLTP when no ligand is 
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bound. The removal of the C4-C52 disulfide bridge allows the N-terminal helix 
more flexibility, and could allow acrylodan to insert into the binding pocket.  Upon 
ligand binding, however, acrylodan is displaced, going from an ordered nonpolar 
environment to a disordered polar environment.  The observed decrease in 
fluorescence emission as palmitate is added is consistent with this hypothesis. 
The engineered mLTP-acrylodan conjugate enables the high-throughput 
screening of the available drug molecules to determine the suitability of mLTP as 
a drug-delivery carrier. With the small size of the protein and high-resolution 
crystal structures available, this protein is a good candidate for computational 
protein design.  The placement of the fluorescent probe away from the binding 
site allows the binding pocket to be designed for binding to specific ligands. 
enabling protein design and directed evolution of mLTP for specific binding to 
drug molecules for use as a carrier.  
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Figure 3-1.  Ribbon representation of non-specific lipid-transfer protein 
from maize (mLTP).  mLTP, a ns-LTP1 is shown bound to palmitatic acid, a fatty 
acid.  Like all ns-LTP1s, it has eight conserved Cys, which form four disulfide 
bridges, shown in stick in orange.  Palmitic acid is shown in spheres, with 
carbons in magenta, and oxygens in red.  The disulfide bridge C4-C52 is circled 
in a, and in b, the C50-C89 pair is circled.  Previous computational design work 
had created stable mutants of mLTP with the removal of each disulfide bridge. 
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Figure 3-2. Acrylodan and its conjugation site on mLTP C52A.  a.  Structure 
of acrylodan;  b.  Ribbon representation of mLTP C52A.  Palmitate (magenta), 
Ala52 (green), and Cys4 (cyan) are shown in space-filling models.  Acrylodan is 
conjugated to the sulfur atom shown in orange.  The distance between the sulfur 
atom and the closest carbon atom on palmitate is ~14 Å. 
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Figure 3-3.  Circular dichroism wavelength scans of the four protein-
acrylodan conjugates.  Each conjugate shows the characteristic minimum near 
208nm and 222nm for helical proteins.  C52A/4C-Ac is most like wild-type mLTP.   
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Figure 3-4.  Fluoresence emission scans of mLTP-acrylodan conjugates.  
Excitation at 363 nm. Protein, λmax: C50A/89C-Ac, 444 nm;  C89E/50C-Ac, 464 
nm;  C52A/4C-Ac, 456 nm; and C4H/N55E/52C-Ac, 476 nm.  In both C4-C52 and 
C50-C89, acrylodan in the more buried positions on the protein caused the 
spectra to be shifted compared to its more exposed partners. 
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Figure 3-5.  Titration of C52A/C4-Acrylodan with palmitate monitored by 
fluorescence emission.  a. Fluorescence emission scans of C52A/4C-Ac (red) 
decreases as increasing concentration of sodium palmitate is added.  Only a 
subset of experimental data is shown. Excitation wavelength is 363nm.  b.  
Fluorescence monitored at 466nm was used to fit equation 3-1. Kd is dertermined 
to be 66 ± 27 nM. 
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Figure 3-6.  Thermal denaturations of C52A/4C-A monitored by CD.  The 
increase in apparent Tm from 59°C for protein alone to 66°C for protein with 
palmitate indicates binding of palmitate to C52A/4C-Ac.  The denaturation was 
not reversible, therefore the standard two-state model could not be used to fit the 
curve. 
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Figure 3-7.  Space filling representation of mLTP C52A.  Protein is shown in 
cyan, palmitate in magenta, while the sulfur atom of Cys4, the site of acrylodan 
conjugation, is shown in orange.  Cys4 is on the surface of the protein, away from 
the binding pocket where palmitate binds. 
Cys4 
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Chapter 4 
 
Designed Enzymes for Ester Hydrolysis  
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Introduction 
One of the tantalizing promises protein design offers is the ability to design 
proteins with specified uses.  If one could design enzymes with novel functions 
for the synthesis of industrial chemicals and pharmaceuticals, the processes 
could become safer and more cost- and environment-friendly.  To date, 
biocatalysts used in industrial settings include natural enzymes, catalytic 
antibodies, and improved enzymes generated by directed evolution.1  Great 
strides have been made via directed evolution, but this approach requires a high-
throughput screen and a starting molecule with detectible base activity.  Directed 
evolution is extremely useful in improving enzyme activity, but it cannot introduce 
novel functions to an inert protein.  Selection using phage display or catalytic 
antibodies can generate proteins with novel function, but the power of these 
methods is limited by the use of a hapten and the size of the library that is 
experimentally feasible.2   
Computational protein design is a method that could introduce novel 
functions.  There are a few cases of computationally designed proteins with novel 
activities, the first of which is the “protozyme” PZD2 designed to hydrolyze p-
nitrophenylacetate (PNPA) into p-nitrophenol and acetate.3  This enzyme was 
built on the scaffold of the oxidation-reduction protein thioredoxin from E. coli.  
Bolon and Mayo utilized the “compute and build” model to create a cavity in 
thioredoxin that was complementary to the substrate.  In the design, they fixed 
the substrate to the catalytic residue (His) by modeling a covalent bond and built 
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a rotamer library for the His-PNPA complex (Figure 4-1) by varying its rotatable 
bonds.  The new rotamers, which model the high-energy state, are placed at 
different residue positions in the protein in a scan to determine the optimal 
position for the catalytic residue and the necessary mutations for surrounding 
residues.  This method generated a protozyme with rate acceleration on the 
order of 102.  In 2003, Looger et al. successfully designed an enzyme with 
triosephosphate isomerase (TIM) activity onto scaffolds of periplasmic binding 
proteins.4  They used a method similar to that of Bolon and Mayo after first 
selecting for a protein that bound to the substrate.  The resulting enzyme 
accelerated the reaction by 105, compared to 109 for wild-type TIM.   
 PZD2 was the first experimental validation of the design method, so it is 
not surprising that its rate acceleration is far less than that of natural enzymes.  
PZD2 has four anionic side chains located near the catalytic histidine.  Since the 
substrate is negatively charged, we thought that the anionic side chains might be 
repelling the substrate leading to PZD2s low efficiency.  To test this hypothesis,  
we mutated anionic amino acids near the catalytic site to neutral ones and 
determined the effect on rate acceleration. We also wanted to validate the design 
process using a different scaffold.  Is the method scaffold independent?  Would 
we get similar rate accelerations on a different scaffold?  To answer these 
questions, we used our design method to confer PNPA hydrolysis activity into T4 
lysozyme, a protein that has been well characterized.5-10 
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Materials and Methods 
Protein Design with ORBIT 
 T4 lysozyme (PDB ID 1L63) was minimized briefly and designed using the 
ORBIT (Optimization of Rotamers by Iterative Techniques) protein design 
software suite.11  A new rotamer library for the His-PNPA high energy state 
rotamer (HESR) was generated using the canonical chi angle values for the 
rotatable bonds as described.3 The HESR library rotamers were sequentially 
placed at each non-glycine, non-proline non-cysteine residue position, and the 
surrounding residues were allowed to keep their amino acid identity or be 
mutated to alanine to create a cavity. The design parameters and energy function 
used were as described.3  The active site scan resulted in Lysozyme 134, with 
the HESR placed at position 134. 
 Two variants, Rbias1.0 and Rbias2.5, (designed by Dan Bolon), focused 
on the catalytic positions of T4 lysozyme.  He placed the HESR at position 26 
and repacked the surrounding residues, incorporating ORBIT’s RBIAS module.12  
RBIAS provides a way to bias sequence selection to favor interactions with a 
specified molecule or set of residues.  In this case, the interactions between the 
protein and the HESR were scaled by 1.0 (no bias applied) and 2.5 (interaction 
energies are multiplied by 2.5) respectively.   
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Protein Expression and Purification 
 Thioredoxin mutants generated by site-directed mutagenesis (D10N, 
D13N, D15N, E85Q, and double mutant D13N_E85Q) were expressed as 
described.3 The T4 lysozyme gene and mutants were cloned into pET11a and 
expressed in BL21-DE3 (Gold) cells from Stratagene. In addition to the designed 
mutations, D20N was incorporated to decrease the intrinsic activity of lysozyme 
and help protein expression.  The wild-type His at position 31 was mutated to 
Gln.  The cells were induced with IPTG at OD600 between 0.7 and1.0, and grown 
at 37 °C for 3 hours.  The cells were lysed by sonication and protein was purified 
by FPLC and dialyzed into 10 mM sodium phosphate, pH 7.0.  Lysozyme 134 
was expressed in the soluble fraction, and purified first by ion exchange, followed 
by size exclusion gel filtration.  Rbias1.0 and Rbias2.5 were in inclusion bodies.  
Induction temperatures of 30°C and 25°C were tried, but the two Rbias mutants 
were still insoluble.  The pellet was washed with 50 mM Tris, 10 mM EDTA, 1 M 
urea, and 1% Triton-X100 three times and centrifuged.  The remaining pellet was 
solubilized in buffer containing 4 M guanidine hydrochloride, purified by gel 
filtration in the same buffer and concentrated.  The Hampton Research (Aliso 
Viejo, CA) Fold-It Screen was used to find a suitable buffer condition for protein 
folding.  After CD wavelength scans to verify proper folding, buffer #15 (55 mM 
MES pH 6.5, 10.56 mM NaCl, 0.44 mM KCl, 1.1 mM EDTA, 440 mM sucrose, 
550 mM L-arginine) was chosen and proteins were refolded, and then dialyzed 
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into 50 mM NaPi (pH 7.0) with 44 mM sucrose.  Proteins were verified to be 
folded after dialysis by circular dichroism. 
 
Circular Dichroism 
Circular dichroism (CD) data were obtained on an Aviv 62A DS 
spectropolarimeter equipped with a thermoelectric cell-holder.  Wavelength scans 
and thermal denaturation data were obtained from samples containing 10 μM 
protein in 25 mM sodium phosphate, pH 7.05.  For wavelength scans, data were 
collected every 1 nm from 250 to 190 nm with an averaging time of 1 second; 
values from three scans were averaged. For thermal studies, data were collected 
every 1°C from 1°C to 99°C using an equilibration time of 120 seconds and an 
averaging time of 30 seconds.  As the thermal denaturations were not reversible, 
we could not fit the data to a two-state transition.  The apparent Tms were 
obtained from the inflection point of the data.   
 
Protein Activity Assay 
 Assays were performed as described in Bolon and Mayo3 with 4 µM 
protein.  Km and Kcat were determined from nonlinear regression fits using 
KaleidaGraph. 
 
Results  
Thioredoxin Mutants 
50
 The computationally designed “protozyme” PZD2 had four anionic amino 
acids (D10, D13, D15, and E85) within 10 Å of the catalytic His17 (Figure 4-1).  
One rationale for the low rate acceleration of PZD2 is that the anionic amino 
acids repelled the negatively charged substrate, p-nitrophenylacetate (PNPA).  
We mutated the anionic amino acids to their neutral counterparts to generate the 
point mutants D10N, D13N, D15N, and E85Q, and also constructed a double 
mutant, D13N_E85Q, by mutating the two positions closest to the His17.  The 
rate of PNPA hydrolysis was determined with Briggs-Haldane steady state 
treatment (Table 4-1).  The five mutants all shared the same order of rate 
acceleration as PZD2.  It seems that the anionic side chains near the catalytic 
His17 are not repelling the negatively charged substrate significantly. 
 
T4 Lysozyme Designs 
 The T4 lysozyme variants, Rbias1.0 and Rbias2.5 were designed 
differently from 134.  134 was designed by an active site scan in which the HESR 
were placed at all feasible positions on the protein and all other residues were 
allowed wild type to alanine mutations, the same way PZD2 was designed.  134 
ranked high when the modeled energies were sorted.  The Rbias mutants were 
designed by focusing on one active site.  The HESR was placed at the natural 
catalytic residues, 11, 20 and 26 in three separate calculations. Position 26 was 
chosen for further design in which the neighboring residues were designed to 
pack against the HESR.  The sequences of 134, Rbias1.0 and Rbias2.5 are 
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compared in Figure 4-2.  134 is a fourfold mutant of lysozyme: D20N was made 
to reduce the native activity of the enzyme and to aid in protein expression; H31Q 
was incorporated to get rid of the native histidine and ensure that any observable 
activity is a result of the designed histidine; the A134H and Y139A mutations 
resulted directly from the active site scan (Figure 4-3).   
 The activity assays of the three mutants showed 134 to be active with the 
same order of rate acceleration as PZD2 (Table 4-2).  Circular dichroism studies 
of 134 show it to be folded, with a wavelength scan and thermal denaturation 
comparable to wild-type lysozyme;8 it exhibits irreversible unfolding upon thermal 
denaturation and has an apparent Tm of 54ºC (Figure 4-4). 
Rbias1.0 and Rbias2.5 are both ten-fold mutants of lysozyme, including 
nonpolar to polar and polar to nonpolar mutations.  They were refolded from 
inclusion bodies and CD wavelength scans had the same characteristics as wild-
type lysozyme though signal intensity was only 10% of wild-type lysozyme.  Their 
solubility in buffer was severely compromised and they did not accelerate PNPA 
hydrolysis above buffer background.   
 
Discussion 
The similar rate acceleration obtained by lysozyme 134 compared to 
PZD2 is reflective of the fact that the same design method was used for both 
proteins.  This result indicates that the design method is scaffold independent.  
The Rbias mutants were designed to test the method of utilizing the native 
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catalytic site and additionally stabilizing the HESR in an attempt to stabilize the 
enzyme-transition state complex.   It is unfortunate that the mutations have 
destabilized the protein scaffold and affected its solubility. 
 Since this work was carried out, Michael Hecht and co-workers have 
discovered PNPA-hydrolysis-capable proteins from their library of four-helix 
bundles.13  The combinatorial libraries were made by binary patterning of polar 
and nonpolar amino acids to design sequences that are predisposed to fold.  
While the reported rate acceleration of 8700 is much higher than that of PZD2 or 
lysozyme 134, the sequence of S-824 contains 12 histidines and 8 lysines.  We 
do not know if all of them are involved in catalysis, but it is certain that multiple 
side chains are responsible for the catalysis.  For PZD2, it was shown that only 
the designed histidine is catalytic.   
However, what is clear is that the simple reaction mechanism and low 
activation barrier of the PNPA hydrolysis reaction make it easier to generate de 
novo enzymes to catalyze the reaction.  While PZD2 showed the necessity of a 
cavity for PNPA binding, it seems that the reaction is promiscuous and a 
nonspecific cavity with a nucleophilic side chain of the proper pKa is sufficient for 
PNPA hydrolysis.  Our design calculations have not taken side chain pKa into 
account; it may be necessary to incorporate this into the design process in order 
to improve PZD2 and lysozyme 134 activity. 
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 a.        b. 
 
 
 
 
 
 
 
 
 
Figure 4-1. Ribbon model of PZD2 and structure of His-substrate high 
energy state rotamer.  a.  PZD2: the His-substrate High Energy State Rotamer 
is shown in red at residue 17.  Four anionic residues within 10 Å of the catalytic 
His17 are shown in magenta (hydrogens not shown).  b.  Structure of the high 
energy state rotamer.  Adapted from Bolon and Mayo.3   
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Table 4-1.  Kinetic parameters of PZD2 and variants for PNPA hydrolysis. 
 Distance to His17 (Å) Km (µM) Kcat (s
-1) Kcat/Kuncat 
PZD2 not applicable 170±20 4.6±0.2*10-4 180 
D13N 3.6 201±58 7.0±0.6*10-4 129 
E85Q 4.9 289±122 9.8±1.5*10-4 131 
D15N 6.2 729±801 10.8±5.5*10-4 123 
D10N 9.6 183±48 22.2±1.8*10-4 138 
D13N_E85Q not applicable 197±63 3.3±0.3*10-4 131 
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Figure 4-2.  Sequence comparison of wild-type T4 lysozyme with 134, 
Rbias1.0 and Rbias2.5.  The catalytic histidines are highlighted by the red 
boxes.  134 was designed in the same way as PZD2 to generate a cavity for the 
HESR, while Rbias mutants were designed primarily for stabilization of the 
neighboring residues with HESR.  WT: wild-type T4 lysozyme. 
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Figure 4-3.  Lysozyme 134 highlighting the essential residues for catalysis.  
A134H and Y139A are the direct results of the active site scan on T4 lysozyme.  
HESR is placed at 134 and Y139 is mutated to Ala to create the necessary 
cavity.  Residue 26 is shown in green to highlight the proposed active site of 
Rbias1.0 and Rbias2.5.  HESR is shown in CPK-inspired colors. 
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Figure 4-4.  Circular dichroism characterization of lysozyme 134.  a.  
Wavelength scan showing characteristic α-helical minimums at 208 and 222 nm.  
b.  Thermal denaturation showing apparent Tm of 54°C. 
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Table 4-2.  Kinetic parameters of lysozyme 134 compared to PZD2 for 
PNPA hydrolysis. 
 
 T4 Lysozyme 134  
PZD2 
 
Kcat 
 
6.01*10-4 (M*s-1) 
 
4.6*10-4(M*s-1) 
 
Kcat/Kuncat 
 
130 
 
180 
 
KM 
 
196 µM 
 
170 µM 
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Chapter 5 
 
Enzyme Design:   
Toward the Computational Design of a Novel Aldolase 
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Enzyme Design 
 Enzymes are efficient protein catalysts.  The best enzymes are limited 
only by the diffusion rate of substrates into the active site of the enzyme.  Another 
major advantage is their substrate specificity and stereoselectivity to generate 
enantiomeric products.  A few enzymes are already used in organic synthesis.1 
Synthesis of enantiomeric compounds is especially important in the 
pharmaceutical industry.1, 2 The general goal of enzyme design is to generate 
designed enzymes that can catalyze a specified reaction.  Designed enzymes 
are attractive industrially for their efficiency, substrate specificity, and 
stereoselectivity.  
To date, directed evolution and catalytic antibodies have been the most 
proficient methods of obtaining novel proteins capable of catalyzing a desired 
reaction.  However, there are drawbacks to both methods.  Directed evolution 
requires a protein with intrinsic basal activity, while catalytic antibodies are 
restricted to the antibody fold and have yet to attain the efficiency level of natural 
enzymes.3 Rational design of proteins with enzymatic activity does not suffer 
from the same limitations.  Protein design methods allow new enzymes to be 
developed with any specified fold, regardless of native activity.  
The Mayo lab has been successful in designing proteins with greater 
stability, and now we have turned our attention to designing function into 
proteins.  Bolon and Mayo completed the first de novo design of an enzyme, 
generating a novel esterase, PZD2 on the E. coli thioredoxin scaffold.4  PZD2 
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catalyzes the ester hydrolysis of p-nitrophenyl acetate (PNPA) into p-nitrophenol 
and acetate with histidine as the catalytic nucleophile.  PZD2 exhibits “burst” 
phase kinetics characteristic of enzymes, with kinetic parameters comparable to 
those of early catalytic antibodies.  The “compute and build” method was 
developed to generate this “protozyme” and can be applied to generate proteins 
with other functions.  In addition to obtaining novel enzymes, we hope to gain 
insight into the evolution of functions and the sequence/structure/function 
relationship of proteins. 
 
“Compute and Build” 
 The “compute and build” method takes advantage of the transition-state 
stabilization theory of enzyme kinetics.  This method generates an active site with 
sufficient space to fit the substrate(s) and places a catalytic residue in the proper 
orientation.  In generating PZD2 to catalyze the ester hydrolysis of PNPA, a high-
energy state of the histidine-catalyzed PNPA hydrolysis reaction pathway was 
modeled as a series of His-PNPA rotamers.4  Rotamers are discrete 
conformations of amino acids (in this case, the substrate (PNPA) was also 
included).5 The high-energy state rotamer (HESR) was placed at each residue on 
the protein to find a proficient site.  Neighboring side chains were allowed to 
mutate to Ala to create the necessary cavity.  The protozymes generated by this 
method do not yet match the catalytic efficiency of natural enzymes.  However, 
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the activity of the protozymes may be enhanced by improving the design 
scheme. 
 
Aldolases 
 To demonstrate the applicability of the design scheme we chose a carbon-
carbon bond-forming reaction as our target function, the aldol reaction.  The aldol 
reaction is the chemical reaction between two aldehyde/ketone groups, yielding a 
β-hydroxy-aldehyde/ketone, which can be condensed by acid or base to afford 
an enone.  It is one of the most important and utilized carbon-carbon bond 
forming reactions in synthetic chemistry (Figure 5-1).  While synthetic methods 
have been successful, they often require multiple steps with protecting groups, 
preactivation of reactants and various reagents.6  Therefore, it is desirable to 
have one-pot syntheses with enzymes that can catalyze specified reactions due 
to their superiority in efficiency, substrate specificity, stereoselectivity, and ease 
of reaction.  While natural aldolases are efficient, they are limited in their 
substrate range.  Novel aldolases that catalyze reactions between desired 
substrates would prove a powerful synthetic tool. 
 There are two classes of natural aldolases.  Class I aldolases use the 
enamine mechanism in which the amino group of a catalytic Lys is covalently 
linked to the substrate to form a Schiff base intermediate.  Class II aldolases are 
metalloenzymes that use the metal to coordinate the substrate’s carboxyl 
oxygen.  Catalytic antibody aldolases have been generated by the reactive 
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immunization method where a reactive “hapten” is used to elicit antibodies with 
catalytic residues at the active site.7-9  The catalytic antibodies 33F12 and 38C2 
use the enamine mechanism of class I aldolases (Figure 5-2).  This mechanism 
involves the nucleophilic attack of the carbonyl C of the aldol donor by the 
unprotonated amino group of the Lys side chain to form Schiff base 1.  The Schiff 
base isomerizes to form enamine 2, which undergoes further nucleophilic attack 
of the carbonyl C of the aldol acceptor.  The resulting Schiff base 3 hydrolyzes to 
form high-energy state 4 which rearranges to release a β-hydroxy ketone without 
modifying the Lys side chain.7 
The aldol reaction is an attractive target for enzyme design due to its 
simplicity and wide use in synthetic chemistry.  It requires a single catalytic 
residue, Lys, with a shifted pKa such that it is unprotonated.  The intrinsic pKa of 
Lys is 10.0,10 yet pH studies of the catalytic Lys in 33F12 and 38C2 suggest that 
the pKa of Lys is perturbed to 5.5 and 6.0 respectively.7  The pKa of Lys can be 
perturbed when in proximity to other cationic side chains, or when located in a 
local hydrophobic environment.  The 2.15 Å crystal structure of the Fab’ antigen-
binding fragment of 33F12 reveals that the catalytic LysH93 is in a deep 
hydrophobic pocket (more than 11 Å deep), with mostly hydrophobic side chains 
within 4 Å (Figure 5-3).  LysH93 is in van der Waals contact with residues LeuH4, 
MetH34, ValH37, CysH92, IleH94, TyrH95, SerH100, TyrH102, and TrpH103.  This feature is 
conserved in 38C2, which differs from 33F12 by 9 amino acids each in VL and 
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VH.7 Clearly, in the absence of nearby cationic side chains a hydrophobic 
environment is required to keep LysH93 unprotonated in its unliganded form.  
Unlike natural aldolases, the catalytic antibody aldolases exhibit broad 
substrate range.  In fact, over 100 aldehyde-aldehyde, aldehyde-ketone, and 
ketone-ketone aldol addition or condensation reactions have been catalyzed by 
33F12 and 38C2.7  This lack of substrate specificity is an artifact of the reactive 
immunization method used to raise them.  Unlike catalytic antibodies raised with 
unreactive transition-state analogs, this method selects for reactivity instead of 
molecular complementarity.  While these antibodies are useful in synthetic 
endeavors,11, 12 their broad substrate range can become a drawback.   
 
Target Reaction 
 Our goal was to generate a novel aldolase with the substrate specificity 
that a natural enzyme would exhibit.  As a starting point, we chose to catalyze the 
reaction between benzaldehyde and acetone (Figure 5-4). We chose this 
reaction for its simplicity.  Since this is one of the reactions catalyzed by the 
antibodies, it would allow us to directly compare our aldolase to the catalytic 
antibody aldolases.  Intermolecular aldol reactions of acetone with aldehydes can 
be catalyzed by primary and secondary amines, including the amino acid 
proline.13-15  Select kinetic parameters are shown in Table 5-1 for the proline- and 
catalytic antibody-catalyzed asymmetric aldol reaction of benzaldehyde with 
acetone (other primary and secondary amines have yields similar to that of 
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proline).  Catalytic antibodies are more efficient than proline, with better 
stereoselectivity and yields.  
 
Protein Scaffold 
 A protein scaffold that is inert relative to the target reaction is required for 
our design process.  A survey of the PDB database shows that all known class I 
aldolases are (α/β)8, or TIM, barrels.  In fact, this fold accounts for ~10% of all 
known proteins and all but one, Narbonin, are enzymes.16  The prevalence of the 
fold and its ability to catalyze a wide variety of reactions make it an interesting 
system to study.  Many (α/β)8 proteins have been studied to learn how barrel 
folds have evolved to have so many chemical functionalities.  Debate continues 
as to whether all (α/β)8 proteins evolved from a single ancestor, or if the (α/β)8 
fold is just a stable structure to which numerous enzymes converged.  The IgG 
fold of antibodies and the (α/β)8 barrel represent two general protein folds with 
multiple functions.  By using an (α/β)8 scaffold, in addition to catalytic antibodies, 
we can examine two distinct folds that catalyze the same reaction.  These studies 
will provide insight into the relationship between the backbone structure and the 
activity of an enzyme. 
 In 2004, Dwyer et al. successfully engineered TIM activity into ribose 
binding protein (RBP), from the periplasmic binding protein family.17  RBP is not 
catalytically active, but through both computational design and selection and 18-
20 mutations, the new enzyme accomplishes 105-106 rate enhancement.  The 
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periplasmic binding proteins have also been engineered into biosensors for a 
variety of ligands, including sugars, amino acids and dipeptides.18  The high-
energy state of the target aldol reaction is similar in size to the ligands, and the 
success of Dwyer et al. has shown RBP to be tolerant to a large number of 
mutations.  We tried RBP as a scaffold for the target aldol reaction as well. 
 
Testing of Active Site Scan on 33F12 
 The success of the aldolase design depends on our design method, the 
parameters we use, and the accuracy of the high energy state rotamer (HESR).  
Luckily, the crystal structure of the catalytic antibody 33F12 is available.  We 
decided to test whether our design method could return the active site of 33F12. 
To test our design scheme, we decided to perform an active site scan on 
the 2.15 Å crystal structure of the 33F12 Fab’ antigen binding fragment (PDB ID: 
1AXT), which catalyzes our desired reaction.  If the design scheme is valid, then 
the natural catalytic residue, LysH93, with lysine on heavy chain position 93, 
should be within the top results from the scan.  The structure of 33F12, which 
contains the “light” and “heavy” chains (Figure 5-5), was renumbered (LysH93 
became LysH99) and energy minimized for 50 steps.  The constant region of the 
Fab was removed, and the antigen binding region, residues 1-114 of both chains, 
was scanned for an active site.   
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Hapten-like Rotamer 
First, we generated a set of rotamers that mimicked the hapten used to 
raise the catalytic antibodies (Figure 5-6).  The hapten used was a β-diketone, 
which serves as a trap for the ε-amino group of a reactive lysine.  A reactive 
lysine has a perturbed pKa, leaving an unprotonated ε-amino group.  The amino 
group undergoes nucleophilic attack of the carbonyl carbon, causing the hapten 
to be covalently linked to the lysine and to absorb  with λmax at 318 nm.  We 
modeled our hapten-like rotamer after the hapten-linked reactive lysine, with a 
methyl group in place of the long R group to facilitate the design calculations.   
The rotamer was first built in BIOGRAF, with standard charges assigned; 
the rotatable bonds were allowed to assume the canonical values of 60°, -60°, 
and 180°, or 90°, -90° and 180° depending on the hybridization states.  First, 
rotamers with all combinations of the different dihedral angles were modeled, and 
their energies were determined without minimization.  The rotamers with severe 
steric clashes, as evidenced by energies >10,000 kcal/mol, were eliminated from 
the list.  The remainder rotamers were minimized and the minimized energies 
were compared to further eliminate high energy rotamers to keep the rotamer 
library a manageable size.  In the end, 14766 hapten-like rotamers were kept 
with minimized energies from 43.8--51.1 kcal/mol.  This is a narrow range for 
ORBIT energies. The set of rotamers were then added to the current rotamer 
libraries.5  They were added to the backbone-dependent e0 library where no χ 
angles were expanded, e2 library where both χ1 and χ2 angles of all amino acids 
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were expanded ±standard deviation, and the a2h1p0 library where the aromatic 
side chains were expanded for both χ1 and χ2, other hydrophobic residues  were 
expanded for χ1, and no expansion used for polar residues. 
With the new rotamers, we performed the active site scan on 33F12 first 
with the a2h1p0 library.  We scanned residues 1-114 (the antigen binding region) 
of both the light and heavy chains by modeling the hapten-like rotamer at each 
qualifying position and allowed surrounding residues to be mutated to Ala to 
create the necessary space.  Standard parameters for ORBIT were used, with 
0.9 as the van der Waals radii scale factor, and type II solvation.  The results 
were then sorted by residue energy or total energy (Table 5-2).  Residue energy 
is the interaction energies of the rotamer with other side chains, and total energy 
is the total modeled energy of the molecule with the rotamer.  Surprisingly, the 
native active site, LysH99, with Lys on residue 99 of the heavy chain, is not in the 
top 10 when sorted by residue energy, but is the second best energy when 
sorted by total energy.  When sorted by total energy, we see the hapten-like 
rotamer is only half buried, as expected.  The first one that is mostly buried (%b-T 
> 90%) is 33H, which is the top hit when sorting by total energy, with the native 
active site 99H second.  Upon closer examination of the scan results, we see that 
33H and 99H are lining the same cavity, and they put the hapten-like rotamer in 
the same cavity, therefore identifying the active site correctly.   
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HESR 
 Having correctly identified the active site with the hapten-like rotamer, we 
had confidence in our active site scan method.  We wanted to test the library of 
high-energy state rotamers for the target aldol reaction.  33F12 is capable of 
catalyzing over 100 aldol reactions, including the target reaction between 
acetone and benzaldehyde.  An active site scan using the HESR should return 
the native active site. 
 The “compute and build” method involves modeling a high-energy state in 
the reaction mechanism as a series of rotamers.  Kinetic studies have indicated 
that the rate-determining step of the enamine mechanism is the C-C bond-
forming step.13  Of high energy states 3 and 4 shown in Figure 5-2, we chose to 
model 4 as the HESR.  This was chosen instead of Schiff base 3 to allow enough 
space to be created in the active site for water to hydrolyze the product from the 
enzyme.  The resulting rotamer is shown in Figure 5-7.  The nine labeled dihedral 
angles were varied to generate the whole set of HESR.  χ1 and χ2 values were 
taken from the backbone independent library of Dunbrack and Karplus5 which is 
based on a survey of the PDB.  χ3 through χ9 were allowed to be the canonical 
60º, 180º, and -60º.  Since there are two stereocenters, four new “amino acids” 
resulted representing all combinations.  For each new χ angle, the number of 
rotamers in the rotamer list was increased 12-fold.  To keep the library size 
manageable, the orientation of the phenyl ring and the second hydroxyl group 
were not defined specifically.  
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 A rotamer list enumerating all combinations of χ values and stereocenters 
was generated (78732 total). 59839 rotamers with extremely high energies 
(>10000 kcal*mol-1) were eliminated.  The remaining 18893 rotamers were 
minimized to allow for small adjustments, and the internal energies were again 
calculated.  An energy cutoff of 50 kcal*mol-1 was applied to further reduce the 
size of the rotamer set to 16111, 20.5% of the original rotamer list. 
 The set of rotamers were then added to the amino acid rotamer libraries.5 
They were added to the backbone-dependent e0 library where no χ angles were 
expanded (e0_benzal0), e2 library where both χ1 and χ2 angles of all amino 
acids were expanded by one standard deviation (e2_benzal0), and the a2h1p0 
library where the aromatic side chains were expanded for both χ1 and χ2, other 
hydrophobic residues were expanded for χ1, and no expansion used for polar 
residues (a2h1p0_benzal0).  Because the HESR set is already so large, no χ 
angle was expanded.  These then served as the new rotamer libraries for our 
design. 
The active site scan was carried out on the Fab binding region of 33F12 
like above, and the top 10 results are shown in Table 5-3. The a2h1p0_benzal0 
library was used as in scans.  Whether we sort the results by residue energy or 
total energy, the natural catalytic Lys of 33F12 remains one of the 10 best 
catalytic residues, an encouraging result.  A superposition of the modeled vs. 
natural active site shows the Lys side chain is essentially unchanged (Figure 5-
8); χ1 through χ3 are approximately the same.  Three additional mutations are 
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suggested by ORBIT after subtracting out mutations without HES present: TyrL36, 
TyrH95, SerH100 are mutated to Ala in the modeled protein.  No mutation is 
necessary to catalyze the desired reaction.   
The mutations suggested by ORBIT could be due to the lack of flexibility of 
HESR.  The HESR is not expanded around any χ angle, and χ3 through χ9 angles 
are defined by the canonical 60º, 180º, and -60º.  This limits the allowed 
conformations of HESR.  A small variation of ±5º in χ3 could cause a significant 
change in the position of the phenyl ring.  In addition, the HESRs are minimized 
individually; thus the HESR used may not represent the minimized conformation 
in the context of the protein.  This is a limitation of the current method. 
 One way of solving this problem is to generate more HESRs.  Once the 
approximate conformation of HESR is chosen, we can enumerate more rotamers 
by allowing the χ angles to be expanded by small increments.  The new set of 
HESRs can then be used to see if any suggested mutations using the old HESR 
set are eliminated.   
Both sorting by residue energy and total energy returned the native active 
site of 33F12 as 99H is in the top two results.  While the hapten-like rotamer was 
able to identify the active site cavity, the HESR is a better predictor of active site 
residue.  This result is very encouraging for aldolase design as it validates our 
“compute and build” design method for the design of a novel aldolase.  We 
decided to start with TIM as our protein scaffold.  
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Enzyme Design on TIM 
Triosephosphate isomerase (TIM) is the prototypical (α/β)8 barrel.  TIM 
from Trypanosomal brucei brucei (PDB ID 5TIM) was chosen as our protein 
scaffold.  It exists as a dimer with an estimated KD < 10-11 M.19  Mutant monomeric 
versions have been made with decreased activity.19  The 1.83 Å crystal structure 
consists of both subunits (residues 2 to 250) of the dimer (Figure 5-9a).  Subunit 
A is crystallized in the “open” conformation, without any ligand bound.  Subunit B 
is in the “almost-closed” conformation: the active site binds a sulfate ion which 
mimics the phosphate group of the natural substrates, D-glyceraldehyde-3-
phosphate (GAP) and dihydroxyacetone phosphate (DHAP).  The sulfate ion 
causes a flexible loop (loop 6) to fold over the active site.20  This provides a 
convenient system in which two distinct conformations of TIM are available for 
modeling. 
The dimer interface of 5TIM consists of 32 residues, and is defined as any 
residue within 4 Å of the other subunit.  Each subunit inserts a C-terminal loop 
(loop 3) into the other subunit (Figure 5-9b).  A salt bridge network is also present 
with each subunit donating four charged residues (Figure 5-9c).  The natural 
active site of TIM, as with other TIM barrel proteins, is located on the C-terminal 
of the barrel.  The catalytic residues are K13, H95, and E167.  K13 and H95 are 
part of the interface.  To prevent dimer dissociation, the interface residues were 
left “as is” for most of the modeling studies. 
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Active Site Scan on “Open” Conformation    
The structure of TIM was minimized for 50 steps using ORBIT.  For the 
first round of calculations, subunit A, the “open” conformation was used for the 
active site scan, while subunit B and the 32 interface residues were kept fixed.  
The newly generated rotamer libraries e0_benzal0, a2h1p0_benzal0, and 
e2_benzal0 were each tested.  An active site scan involved positioning HESRs at 
each non-Gly, non-Pro, non-interface residue while finding the optimal sequence 
of amino acids to interact favorably with a chosen HESR.  Since the structure of 
TIM shows residues 2 to 250, with 32 interface residues,14 Pro, and 31 Gly (3 at 
interface), each scan generated 175 models with HESR placed at a different 
catalytic residue position in each.  Due to the large size of the protein, it was 
impractical to allow all the residues to vary.  To eliminate residues that are far 
from the HESR from the design calculations, a preliminary calculation was run 
with HESR at the specified positions, with all other residues mutated to Ala.  The 
distance of each residue to HESR was calculated, and those that were within 12 
Å were selected.  In a second calculation, HESR was kept at the specified 
position and the side chains that were not selected were held fixed.  The identity 
of the selected residues (except Gly, Pro, and Cys) was allowed to be either wild 
type or Ala.  Pairwise calculation of solvent-accessible surface area21 was 
calculated for each residue.  In this way, an active site scan using the 
a2h1p0_benzal0 library took about 2 days on 32 processors. 
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 In protein design, there is always a tradeoff between accuracy and speed.  
In this case, using the e2_benzal0 library would provide us greatest accuracy, but 
each scan took ~4 days.  After testing each library, we decided to use the 
a2h1p0_benzal0 library, which provided us with results that differed only by a few 
mutations from the results with the e2_benzal0 library.  Even though a calculation 
using the a2h1p0_benzal0 library is not as fast as the e0_benzal0 library, it 
provides greater accuracy. 
 Both the hapten-like rotamer library and the HESR library were used in the 
active site scan of the open conformation of TIM.  The top 10 results sorted by 
the interaction energy contributed by the HESR or hapten-like rotamer (residue 
energy), or total energy of the molecule, are shown in Table 5-4 and 5-5.  
Overall, sorting by residue energy or total energy gave reasonably buried active 
site rotamers.  Residue positions that are highly ranked in both scans are 
candidates for active site residues. 
 
Active Site Scan on “Almost-Closed” Conformation 
The active site scan was also run with subunit B of TIM, the “almost-
closed” conformation.  This represents an alternate conformation that could be 
sampled by the protein.  There are three regions that are significantly different 
between the two conformations, loop 5 (residues 129-142), loop 6 (167-180), 
referred to as the flexible loop, and loop 7 (212-216).  The movements of the 
loops result in a rearrangement of hydrogen-bond interactions.  The major 
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difference is in loop 6, which connects β6 to H6 (Figure 5-10).  Gly175 of loop 6 
is moved 6.9 Å, while the side chain oxygen atoms of the catalytic residue 
Glu167 are essentially in the same position.20 The same minimized structure 
used in the “open” conformation modeling was used.  The interface residues and 
subunit A were held fixed.  The results of the active site scan are listed in Table 
5-6.  
The loop movements provide significant changes.  Since both 
conformations are accessible states of TIM, we want to find an active site that is 
amenable to both conformations.  The availability of this alternative structure 
allows us to examine more plausible active sites and in fact is one of the reasons 
that Trypanosomal TIM was chosen. 
 
pKa Calculations 
 With the results of the active site scans, we needed an additional method 
to screen the designs.  A requirement of the aldolase is that it has a reactive 
lysine, which is a lysine with lowered pKa.  A good computational screen would 
be to calculate the pKa of the introduced lysines.   
 While pKa calculations are difficult to determine accurately, we decided to 
try the program Multi-Conformation Continuum Electrostatics (MCCE).21, 22  It 
combines continuum electrostatics calculated by DelPhi and molecular 
mechanics force fields in Monte Carlo sampling to simultaneously calculate free 
energy, net charge, occupancy of side chains, proton positions, and pKa of 
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titratable groups.23 DelPhi implements the finite-difference Poisson-Boltzmann 
(FDPB) method to calculate electrostatic interactions.24, 25 
 To test the MCCE program, we ran some test cases on ribonuclease T1, 
phosphatidylinositol-specific phospholipase C, xylanase, and finally 33F12.  Of 
the 17 titratable groups, 9 were within 1 pH unit of the experimentally determined 
pKa, 2 were within 2 pH units, and 6 were >2 pH units away (Table 5-7).  MCCE 
is the only pKa program that allows the side chain conformations to vary, and is 
thus the most appropriate for our purpose.  However, it is not accurate enough to 
serve as a computational screen for our design results currently. 
 
Design on Active Site of TIM 
 A visual inspection of the results of the active site scan revealed that, in 
most cases, the HESR was insufficiently buried.  Due to the requirement of the 
reactive lysine, we needed to insert a Lys into a hydrophobic environment.  None 
of the designs put the Lys in a deep pocket.  Also, with the difficulty of generating 
a new active site, we decided to focus on the native catalytic residue, Lys13.  The 
natural active site already has a cavity to fit its substrates.  It would be interesting 
to see if we can mutate the natural active site of TIM to catalyze our desired 
reaction.  Since Lys13 is part of the interface, it was eliminated from earlier active 
site scans.  In the current modeling studies, we are forcing HESR to be placed at 
residue 13, in both the “open” and “almost-closed” conformations.  Because the 
protein is a symmetrical dimer, any residue on one subunit must be tolerated by 
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the other subunit.  The results of the calculation are shown in Table 5-8.  
Interestingly, the “open” conformation led to more HES burial.  After subtracting 
out the mutations that ORBIT predicts with the natural Lys conformation present 
instead of HESR for subunit A, one mutation (Ile172 to Ala) remains.  Ile172 is in 
van der Waals clash with HESR, so it is mutated to Ala.   
 The HESR is only ~80% buried as QSURF calculates, and in fact, the 
rotamer looks accessible to solvent.  Additional modeling studies were conducted 
in which the optimized residues are not limited to their wild type identities or Ala, 
however, due to the placement of Lys13 on a surface loop, the HESR is not 
sufficiently buried.  The active site of TIM is not suitable for the placement of a 
reactive lysine. 
Next, we turned to the ribose binding protein as the protein scaffold.  At 
the same time, there had been improvements in ORBIT for enzyme design.  
SUBSTRATE and GBIAS were two new modules added.  SUBSTRATE executes 
user-specified rotational and translational movements on a small molecule 
against a fixed protein, and GBIAS will add a bias energy to all interactions that 
satisfy user-specified geometry restraints.  GBIAS is a quick way to eliminate 
rotamers that do not satisfy the restraints prior to calculation of interaction 
energies and optimization steps, which are the most time consuming steps in the 
process.  Since GBIAS is a new module, we first needed to test its effectiveness 
in enzyme design. 
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GBIAS 
 In order to test GBIAS, we decided to use a natural aldolase.  2-keto-3-
deoxy-6-phosphogluconate (KDPG) aldolase was chosen (PDB ID 1EUA).  It is a 
Class I aldolase whose reaction mechanism involves formation of a Schiff base.  
It is a trimer of (α/β)8 barrel and the 1.95 Å crystal structure has a covalent 
intermediate trapped.26  The carbinolamine intermediate between lysine side 
chain and pyruvate was the basis for a new rotamer library, and, in fact, it is very 
similar to the HESR library generated for the acetone-benzaldehyde reaction 
(Figure 5-11).  This is a further confirmation of our choice of HESR.  The new 
rotamer library representing the trapped intermediate was named KPY, and all 
dihedral angles were allowed to be the canonical values of -60º, 60º and 180º. 
We tested GBIAS on one subunit of the KDPG aldolase trimer.  We put 
KPY at residue From the crystal structure, we see the contacts the intermediate 
makes with surrounding residues (Figure 5-12), and except the water-mediated 
hydrogen bond, we put in our GBIAS geometry definition file all the contacts that 
are in the crystal structure, allowing hydrogen bonding distances of 2.4--3.4 Å, 
and donor-hydrogen-acceptor angles between 140º and 180º.  GBIAS energy 
was applied from 0 to 10 kcal/mol, and the results were compared to the crystal 
structure to determine if we captured the interactions.  With no GBIAS energy 
(bias = 0), we do not retain any of the crystallographic hydrogen bonds.  With 
bias energy of 5, we get 1, and with GBIAS energy of 10kcal/mol for each 
satisfied interaction, we do retain all the major interactions (Figure 5-12).   KPY at 
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133 superimposes onto the crystallographic trapped intermediate.  Arg49 and 
Thr73 also superimpose with their wild-type orientation.  The only sidechain that 
differs from the wild type is Glu45, but that is probably due to the fact that water-
mediated hydrogen bonds were not allowed. 
The success of recapturing the active site of KDPG aldolase is a 
testament to the utility of GBIAS.  Without GBIAS, we were not able to retain the 
hydrogen bonds that are present in the crystal structure.  GBIAS was used for the 
focused design on RBP binding site. 
 
Enzyme Design on Ribose Binding Protein 
 The ribose binding protein is a periplasmic transport protein.  It is a two 
domain protein connected by a hinge region, which undergoes conformational 
change upon association with ribose.  It binds ribose in a “clam-shell”-like 
manner, where the domains “close” on the ligand (Figure 5-13).27  RBP binds 
ribose tightly, with Kd of 130nM.  In the closed conformation, Asp89, Asp215, 
Arg91, Arg141, and Asn13 form an extensive hydrogen bonding network with 
ribose in the binding pocket.  Because the binding pocket already has two 
cationic residues, Arg91 and Arg141, we felt this was a good candidate as a 
scaffold for the aldol reaction.  A quick design calculation to put Lys instead of 
Arg at those positions yielded high probability rotamers for Lys.  The HESR also 
has two hydroxl groups that could benefit from the hydrogen bond network 
available. 
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 Due to the improvements in computing and the addition of GBIAS to 
ORBIT, we could process more rotamers than when we first started this project.  
We decided to build a new library of HESR to allow us a more accurate design.  
We added two more dihedral angles to vary.  In addition to the 9 dihedral angles 
in Figure 5-7, the dihedral angle for the second hydroxyl group was allowed to be 
-60°, 60° and 180° while the phenyl ring could rotate as well.  χ1 and χ2 were 
also expanded by ±15°, like that of a true e2 library.  The new rotamer list was 
generated by varying all 11 angles, and rotamers with the lowest energies 
(minimum plus 5) were retained for merging with the backbone dependent 
e2QERK0 library where all residues except Q, E, R, K were expanded around χ1 
and χ2.  The HESR library contained 37,381 rotamers. 
 With the new rotamer library, we placed HESR at position 90 and 141 in 
separate calculations in the closed conformation (PDB ID 2DRI) to determine the 
better site for HESR.  We superimposed the models with HESR at those 
positions with ribose in its crystallographic coordinates (Figure 5-14).  HESR at 
position 141 better superimposed with ribose, meaning it would use the same 
binding residues, so further targeted designs focused on HESR at 141.  For 
these designs, type 2 solvation was used penalizing for burial of polar surface 
area, and HERO obtained the global minimum energy conformation (GMEC).  
Residues surrounding 141 were allowed to be all residues except Met, and a 
second shell of residues were allowed to change conformation but not their 
amino acid identity. The crystallographic conformations of side chains were 
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allowed as well. Residues 215 and 235 were not allowed to be anionic residues 
since an anionic residue so close to the catalytic Lys would make it less likely to 
be unprotonated.  Both geometry and energy pruning was used to cut down the 
number of rotamers allowed so the calculations were manageable.  SBIAS was 
utilized to decrease the number of extraneous mutations by biasing toward the 
wild-type amino acid sequence. It was determined that 4 mutations were 
necessary to accommodate HESR at 141, D89V, N105S, D215A, and Q235L.  
These 4 mutations had the strongest rotamer-rotamer interaction energy with 
HESR at 141.  The final model was minimized briefly and it shows positive 
contacts for HESR with surrounding residues (Figure 5-15).  Both hydroxyl 
groups have the potential to make hydrogen bonds, and the phenyl ring of HESR 
is in a cage of phenyl rings as it is stacked in between the phenyl rings of Phe15 
and Phe164, and perpendicular to Phe16. 
 
Experiemental Results 
 Site-directed mutagenesis was used introduce R141K, D89V, N105S, 
D215V, and Q235L.  Previously, Kyle Lassila had added a His-tag to the RBP 
gene for Ni-NTA column purification.  Wild-type RBP and mutants were 
expressed in BL21(DE3) Gold cells at 37 °C, induction with 1mM IPTG.  Cells 
were harvested and sonicated.  The proteins expressed in the soluble fraction, 
and after centrifugation, were bound to Ni-NTA beads and purified.  All single 
mutants were first made, then different double mutant and triple mutant 
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combinations  containing R141K were expressed along the way.  All proteins 
were verified by SDS-PAGE and MALDI-TOF.  Circular dichroism wavelength 
scans probed the secondary structure of the mutants (Figure 5-16).  
Unfortunately, D89V/N105S/R141K (VSK) and the 5-fold mutant, 
D89V/N105S/R141K/D215A/Q235L (VSKAL) were not folded properly.  
R141K/D215A/Q235L (KAL) and the R141K single mutant both appeared folded, 
with intense minimums at 208nm and 222nm as is characteristic of helical 
proteins.   
 Even though our design was not folded properly, we decided to test the 
protein mutants we made for activity.  The assay we selected was the same one 
used to screen for the catalytic antibodies 33F12 and 38C2.  We incubated the 
proteins with 1,4-pentadione (acetylacetone) and looked for the vinylogous amide 
formation by observing UV absorption.  Acetylacetone is a diketone, a smaller 
diketone than the hapten used to raise the antibodies.  We chose this smaller 
diketone to ensure it could fit in the binding pocket of RBP.  If a reactive Lys was 
present in the binding pocket, the Schiff base would have formed and 
equilibrated to the vinylogous amide which has a λmax of 318nm.  To test this 
method, we first assayed the commercially available 38C2.  To 9 µM of antibody 
in PBS, we added an excess of acetylacetone, and monitored UV absorption 
from 200 to 400nm.  UV absorption increased at 318nm within seconds of adding 
acetylacetone, in accordance with the formation of the vinylogous amide (Figure 
5-17).  This method can reliably show vinylogous amide formation, and therefore 
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is an easy and reliable method to determine whether the reactive Lys is in the 
binding pocket.  We performed the catalytic assay on all the mutants, but did not 
observe an increase in UV absorbance at 318nm.  The mutants behaved the 
same as wild-type RBP and R141K in the catalytic assay, which are shown in 
Figure 5-18.  Incubation with acetone and benzaldehyde also did not lead to 
observation of the product by HPLC. 
 
Discussion 
 As we mentioned above, RBP exists in the open conformation without 
ligand, and in the closed conformation with ligand.  The binding pocket is more 
exposed to the solvent in the open conformation than in the closed conformation.  
It is possible that the introduced lysine is protonated in the open conformation, 
and the energy to deprotonate the side chain is too great.  It may also be that the 
hapten and substrates of the aldol reaction cannot cause the conformational 
change to the closed conformation.  This is a shortcoming of performing design 
calculations on one conformation when there are multiple conformations 
available.  We can not be certain the designed conformation is the dominant 
structure.  In this case, it is better to design on proteins with only one dominant 
conformation.   
The shifted pKa (~6.0) of the catalytic lysine in 33F12 is attributed to its 
burial in a hydrophobic microenvironment without any countercharge.28  
Observations from natural class I adolases show the presence of a second 
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positively charged residue in close proximity to the reactive lysine can also lower 
its pKa.29  The presence of the reactive lysine is essential to the success of the 
project, and we decided to introduce a lysine into the hydrophobic core of a 
protein. 
 
Reactive Lysines 
Buried Lysines in Literature 
 Studies to introduce lysine into the hydrophobic core of E. coli thioredoxin 
led to ΔΔG of -4 kcal*mol-1 and ΔΔCp of approximately -1 kcal*mol-1*K-1.30  The 
reduction in ΔCp is attributed to structural perturbations leading to localized 
unfolding and the exposure of the hydrophobic core residues to solvent.  
Mutations of completely buried hydrophobic residues in the core of 
Staphylococcal nuclease to lysine have led to pKa of 5.6 and 6.4. ΔG for the 
burial of the lysine costs 5-6 kcal/mol.31, 32  The protein unfolds, however, when 
the lysine is protonated, except in the case of a hyperstable mutant of 
Staphylococcal nuclease as the background.33  It is clear the burial of lysine in a 
hydrophobic environment is energetically unfavorable and costly.  A 
compensation for the inevitable loss of stability is to use a hyperstable protein 
scaffold as the background for the mutation.  Two proteins that fit this criteria 
were the tenth fibronectin type III domain (10Fn3) and non-specific lipid transfer 
protein from maize (mLTP).  We tested the burial of lysine in the hydrophobic 
cores of these proteins,.   
87
 Tenth Fibronectin Type III Domain 
 10Fn3 was chosen as a protein scaffold for its exceptional thermostability 
(Tm = 90 °C) and because it is an antibody-mimic.  Its structure is similar to that of 
the variable region of an antibody.34  It is a common scaffold for directed 
evolution and selection studies.  It has high expression in E. coli and is >15mg/ml 
soluble in aqueous solutions.  We scanned the core of 10Fn3 for optimal sites for 
the placement of Lys.  For each residue that is considered “core” by RESCLASS, 
we set the residue to Lys, and allowed the remaining protein to retain their wild-
type identities.  We picked four positions for Lys placement from a visual 
inspection of each resulting model.  They are W22, Y32, I34, and I70 (Figure 5-
19).  Each of the four sidechains extends into the core of the protein along the 
length of the protein.   
 The four mutants were made by site-directed mutagenesis of the 10Fn3 
gene and expressed in E. coli along with the wild-type protein for comparison.  All 
five proteins were highly expressed, but only the wild-type protein was present in 
the soluble fraction and properly folded.  Attempts were made to refold the four 
mutants from inclusion bodies by rapid-dilution, step-wise dialysis, and 
solubilization in buffers with various pH and ionic strength, but the proteins were 
not soluble.  The Lys incorporation in the core had unfolded the protein. 
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mLTP (Non-specific Lipid-Transfer Protein from Maize) 
 mLTP is a small protein with four disulfide bridges that does not undergo 
conformational change upon ligand binding.35  We had successfully expressed 
mLTP in E. coli previously and determined its apparent Tm to be 82 °C.  It binds 
fatty acids and other nonpolar ligands in its deep hydrophobic binding pocket.  
The residues involved in ligand contact (11, 18, 33, 36, 40, 49, 53, 60, 71, 79, 83) 
are all classified as “core” by RESCLASS.  We placed a lysine sidechain in the 
position of each of the ligand-binding residues and allowed the rest of the protein 
to retain their amino acid identity.  From the 11 sidechain placement designs, we 
chose 5 positions to mutate to lysine, I11, A18, V33, A49 and I79 (Figure 5-20).   
 Encouragingly, of the five mutations, only I11K was not folded.  The 
remaining four mutants were properly folded and had apparent Tms above 65 °C 
(Figure 5-21).  The four mutants were tested for reactive lysine by incubating with 
1,4-pentadione as performed in the catalytic assay for 33F12, however no 
vinylogous amide formation was observed.  It is possible that the 1,4-pentadione 
does not conjugate to the lysine due to inaccessibility rather than the lack of 
lowered pKa.  However, additional experiments such as multidimensional NMR 
are necessary to determine if the lysine pKa has shifted. 
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Future Directions 
 Though we were unable to generate a protein with a reactive lysine for the 
aldol condensation reaction, we succeeded in placing lysine in the hydrophobic 
binding pocket of mLTP without destabilizing the protein irrevocably.  The 
resulting mLTP mutants can be further designed for additional mutations to lower 
the pKa of the lysine side chains.   
While protein design with ORBIT has been successful in generating highly 
stable proteins and novel proteins to catalyze simple reactions, it has not been 
very successful in modeling the more complicated aldolase enzyme function.  
Enzymes have evolved to maintain a balance between stability and function.  The 
energy functions currently used have been very successful for modeling protein 
stability, as it is dominated by van der Waal forces; however they do not 
adequately capture the electrostatic forces that are often the basis of enzyme 
function.  Many enzymes use a general acid or base for catalysis, an accurate 
method to incorporate pKa calculation into the design process would be very 
valuable.  Enzyme function is also not a static event as currently modeled in 
ORBIT.  We now know the “lock and key” hypothesis does not adequately 
describe enzyme-substrate interactions.  Multiple side chains often interact with 
the substrate consecutively as the protein backbone flexes and moves.  A small 
movement in the backbone could have large effects on the active site.  Improved 
electrostatic energy approximations and the incorporation of dynamic backbones 
will contribute to the success of computational enzyme design. 
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Figure 5-1.  A generalized aldol reaction.  The aldol condensation reaction of 
an aldehyde and ketone to form an enone.  The hydroxy ketone can be acid or 
base catalyzed to form the enone. 
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Figure 5-2.  The enamine mechanism of catalytic antibody aldolases and 
natural class I aldolases.  Acetone is shown as the aldol donor, though it can 
be substituted by other ketones or aldehydes.  (Figure from Barbas et al., 
Science, 1997)7. 
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Figure 5-3.  Fab’ 33F12 binding site.  Side chains for residues within 4 Å of 
LysH93 are shown.  The light chain is in purple, and heavy chain in green. (Figure 
from Barbas et al., Science, 1997)7. 
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Figure 5-4.  The target aldol addition between acetone and benzaldehyde.  
The product has one stereocenter at the carbon with the hydroxyl group. 
 
 
 
 
99
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5-1  Catalytic parameters of proline and catalytic antibodies. 
 
Parameters for the aldol reaction shown in Figure 5-4. 
Catalyst Yield ee1 (%) Amt. used Kcat/Kuncat Reference 
(L)-Proline 62% 60 20-30 mol % N/A Sakthivel et al. 
200114 
38C2 and 
33F12 
67-82% 
 
>99 0.4 mol % 105 - 107 Hoffmann et 
al. 19988 
 
1ee: enantiomeric excess (%) is calculated as:  ee =  ([A] – [B]) / ([A] + [B]) * 100 
where [A] is the concentration of major enantiomer and [B] the concentration of 
minor enantiomer 
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Figure 5-5.  Structure of Fab' 33F12.  The light chain is in dark and light blue, 
and heavy chain is in yellow and orange.  Residues 1-114 of light chain (dark 
blue) and heavy chain (yellow) were scanned.   Light blue and orange portions 
were treated as "template,", their conformations were not allowed to change.  
Side chain of LysH93 is shown in red. 
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Figure 5-6.  Hapten-like rotamers for active site scan on 33F12.  a.  
Suggested mechanism of the β-diketone hapten 1 trapping the reactive lysine of 
the antibody, to form a β-keto imine that finally tautomerizes into a stable 
enaminone 2, which absorbs with λmax at 318nm.  (Figure from Hoffmann et al., 
JACS, 1998)8  b.  The hapten-like rotamer used to test the active site scan on 
33F12.  Labelled dihedral angles were varied.   The R group was shorted to 
methyl group for ease of design calculations. 
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Sorted by Residue Energy 
 
 
 
 
 
 
 
 
 
 
 
Sorted by Total Energy 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5-2. Top 10 results from active site scan of the Fab’ antigen-binding 
region of 33F12 with hapten-like rotamer. Results are sorted by residue 
energy of the hapten-like rotamer at the active site, or total energy of the 
molecule.  ASresidue: active site residue; %b-P: fraction polar burial of rotamer; 
%b-T: fraction total burial of rotamer; #mutations: number of mutations ORBIT 
predicts.  The energies (kcal mol-1) are calculated by ORBIT using the DREIDING 
force field.  They are not absolute energies.  The natural active site residue is 
highlighted in yellow. 
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Figure 5-7.  High-energy state rotamer with varied dihedral angles labeled.   
One of the four high-energy state rotamer used in the design process.  Labeled 
dihedral angles were varied to generate the series of rotamers. 
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Table 5-3. Top 10 results from active site scan of the Fab’ antigen-binding 
region of 33F12 with HESR. Results are sorted by residue energy of the 
hapten-like rotamer at the active site, or total energy of the molecule.  ASresidue: 
active site residue; %b-P: fraction polar burial of rotamer; %b-T: fraction total 
burial of rotamer; #mutations: number of mutations ORBIT predicts.  The 
energies (kcal mol-1) are calculated by ORBIT using the DREIDING force field.  
They are not absolute energies.  The natural active site residue is highlighted in 
yellow. 
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Figure 5-8.  Superposition of 1AXT with the modeled protein.  The Cα trace is 
shown in green.  LysH93 is in red, HESR (H99 in model) is in blue.  χ1 through χ3 
of the two side chains are approximately the same.  The three additional 
mutations suggested by ORBIT are TyrL36, TyrH95, SerH100 to Ala.  The wild type 
side chains are shown in magenta, and Ala mutations in yellow. 
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Figure 5-9.  Ribbon diagram and Cα  trace of triosephosphate isomerase. 
Crystal structure of 5TIM showing the prototypical (α/β)8 barrel fold.  a.  Subunit A 
is shown in yellow, subunit B in cyan.  b.  Cα trace of both subunits, with the 32 
interface residue sidechains shown in blue.  The interweaving loops are easy to 
distinguish.  A red loop inserts into the green subunit, and vice versa.  c.  The 
interface salt bridge network involving Glu 77, Glu 104, Arg 98, Lys 112.  Anionic 
sidechains are in blue, cationic side chains in orange.  Backbone atoms are in 
red and green. 
 
 
 
 
 
a 
b 
32 Interface Residues: N11, K13, C14, 
N15, G16, S17, Q18, T44, F45, V46 
H47, A49, Q65, N66, I68, S71, G72, 
A73, F74, T75, G76, E77, V78, S79, 
I82, D85, F86, H95, E97, R98, Y101, 
Y102 
 
c 
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Hapten-like Rotamer Library 
 
Sorting by Residue Energy 
 
Sorting by Total Energy 
 
Table 5-4. Top 10 results from active site scan of the open conformation of 
TIM with hapten-like rotamers. Results are sorted by residue energy of the 
hapten-like rotamer at the active site, or total energy of the molecule.  ASresidue: 
active site residue; %b-P: fraction polar burial of rotamer; %b-T: fraction total 
burial of rotamer; #mutations: number of mutations ORBIT predicts.  The 
energies (kcal mol-1) are calculated by ORBIT using the DREIDING force field.  
They are not absolute energies.  Residues that are returned in both lists are 
highlighted in yellow. 
 
 
Rank ASresidue  residueE  totalE  #mutations  %b-H  %b-P  %b-T
1 38 -22.41 -1371.34 6 67.5 34.6 65
2 162 -18.82 -1287.05 10 99.7 94.7 99.3
3 61 -17.84 -1363.4 6 73.7 69.1 73.3
4 104 -16.94 -1336.55 4 85.4 97.7 86.2
5 130 -12.08 -1337.31 6 67.8 99.6 71.1
6 232 -11.1 -1358.49 8 83.9 100 84.8
7 178 -10.87 -1355.94 6 77.1 92.1 78.4
8 176 -9.16 -1284.61 5 65 88.1 66.6
9 122 -8.92 -1335.61 8 69.9 63.9 69.5
10 215 -8.77 -1311.79 3 70.1 79.3 70.8
Rank ASresidue  residueE  totalE  #mutations  %b-H  %b-P  %b-T
1 38 -22.41 -1371.34 6 67.5 34.6 65
2 61 -17.84 -1363.4 6 73.7 69.1 73.3
3 232 -11.1 -1358.49 8 83.9 100 84.8
4 178 -10.87 -1355.94 6 77.1 92.1 78.4
5 55 -0.25 -1348.79 5 57.4 85 59.2
6 31 -3.68 -1345.92 2 59.7 100 63.6
7 5 -5.16 -1344.64 3 68.7 33.3 65.2
8 250 -3.31 -1340.65 3 54.7 24 53.3
9 130 -12.08 -1337.31 6 67.8 99.6 71.1
10 104 -16.94 -1336.55 4 85.4 97.7 86.2
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Table 5-5. Top 10 results from active site scan of the open conformation of 
TIM with HESR. Results are sorted by residue energy of the hapten-like rotamer 
at the active site, or total energy of the molecule.  ASresidue: active site residue; 
%b-P: fraction polar burial of rotamer; %b-T: fraction total burial of rotamer; 
#mutations: number of mutations ORBIT predicts.  The energies (kcal mol-1) are 
calculated by ORBIT using the DREIDING force field.  They are not absolute 
energies.  Residues that are returned in both scans with HESR and scans with 
hapten-like romaters are highlighted in light yellow. 
 
 
Rank ASresidue  residueE  totalE  #mutations  %b-H  %b-P  %b-T
1 242 -39.36 -1339.86 10 100 100 100
2 150 -35.09 -1322.73 8 100 100 100
3 154 -32.94 -1323.87 6 100 100 100
4 51 -24.05 -1333.91 9 100 100 100
5 162 -23.92 -1332.6 8 99.9 100 99.9
6 38 -23.04 -1342.78 4 84.1 58.5 78.3
7 10 -20.78 -1310.41 9 100 100 100
8 246 -20.69 -1299.04 10 100 100 100
9 52 -19.66 -1335.85 4 64.7 29.8 55.1
10 125 -19.58 -1307.44 7 93.1 100 94.3
Rank ASresidue  residueE  totalE  #mutations  %b-H  %b-P  %b-T
1 145 -7.04 -1372.96 5 61 13.2 50
2 179 -5.92 -1368.23 4 82 27.5 72.8
3 5 -17.58 -1365.37 5 64.1 8.5 52.2
4 106 -11.71 -1364.67 5 71.4 12.4 61.9
5 182 -17.52 -1363.92 4 81.2 17.3 70.7
6 185 -11 -1361.87 5 63.1 42.4 59
7 148 -5.78 -1357.62 4 50.7 0.8 40.8
8 55 -10.57 -1356.58 5 66.6 25.2 58.4
9 118 -8.77 -1352.98 3 68.5 7 55.9
10 122 -2.31 -1351.16 4 64.7 39.6 58.9
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Figure 5-10.  Superposition of backbone atoms of “open” and “almost 
closed” conformations of TIM.  Cα trace is shown for each subunit.  “Open” 
conformation (subunit A) is shown in red, and “almost closed” conformation 
(subunit B) is in yellow.  Loop 6 on subunit B folds to trap a sulfate ion. 
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Table 5-6. Top 10 results from active site scan of the almost-closed 
conformation of TIM with HESR. Results are sorted by residue energy of the 
hapten-like rotamer at the active site, or total energy of the molecule.  ASresidue: 
active site residue; %b-P: fraction polar burial of rotamer; %b-T: fraction total 
burial of rotamer; #mutations: number of mutations ORBIT predicts.  The 
energies (kcal mol-1) are calculated by ORBIT using the DREIDING force field.  
They are not absolute energies.  Residues that are highlighted have appeared in 
scans with HESR on the open conformation of TIM.  Residues 55 and 38 have 
appeared in in both scans with HESR and hapten-like rotamers.   
 
 
 
Rank ASresidue  residueE  totalE  #mutations  %b-H  %b-P  %b-T
1 242 -36.91 -1346.72 10 100.0 99.8 99.9
2 21 -31.56 -1287.37 10 99.5 99.9 99.6
3 150 -31.11 -1354.54 7 100.0 100.0 100.0
4 154 -27.6 -1335.81 8 100.0 100.0 100.0
5 142 -23.7 -1391.89 4 82.5 54.0 75.3
6 246 -22.46 -1305.21 9 100.0 99.7 99.9
7 28 -22.41 -1344.82 10 99.1 100.0 99.2
8 194 -21.99 -1301.1 8 100.0 100.0 100.0
9 147 -21.51 -1334.22 10 100.0 100.0 100.0
10 164 -21.29 -1342.59 9 100.0 100.0 100.0
Rank ASresidue  residueE  totalE  #mutations  %b-H  %b-P  %b-T
1 146 -13.91 -1419.67 5 68.4 70.6 68.8
2 191 -13.88 -1414.36 2 67.0 38.8 61.2
3 148 -7.92 -1411.45 4 58.9 2.5 46.8
4 145 -9.22 -1405.24 4 63.6 11.4 53.8
5 111 -16.47 -1397.32 5 82.9 25.0 72.9
6 185 -8.55 -1397.06 3 80.3 34.8 71.0
7 55 -17.24 -1395.29 4 74.8 49.7 68.8
8 38 -14.03 -1394.82 5 76.4 15.1 63.8
9 115 -8.06 -1394.22 3 63.0 5.0 50.3
10 188 -2.87 -1393.53 3 59.2 10.0 50.5
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Protein 
 
Titratable groups 
 
pKaexp 
 
pKacalc 
 
Ribonuclease T1 (9RNT) 
 
His 40 
His 92 
 
7.9 
7.8 
 
8.5 
6.3 
 
Phosphatidylinositol-specific 
phospholipase C (PI-PLC: 
1GYM) 
 
His 32 
His 82 
His 92 
His 227 
 
7.6 
6.9 
5.4 
6.9 
 
< 0.0 
7.8 
5.8 
7.3 
 
Xylanase (1XNB) 
 
Glu 78 
Glu 172 
His 149 
His 156 
Asp 4 
Asp 11 
Asp 83 
Asp 101 
Asp 119 
Asp 121 
 
4.6 
6.7 
< 2.3 
6.5 
3.0 
2.5 
< 2 
< 2 
3.2 
3.6 
 
7.9 
5.8 
< 0.0 
6.1 
3.9 
3.4 
6.1 
9.8 
1.8 
4.6 
 
Cat. Ab. 33F12 (1AXT) 
 
Lys H99 
 
5.5 
 
2.1 
 
 
Table 5-7.  Results of MCCE pKa calculations on test proteins. Of the 17 
titratable groups, 9 were within 1 pH unit of the experimentally determined pKa 
(highlighted in red).   
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Table 5-8.  Results of modeling the HESR at Lys 13, the natural catalytic 
residue.  Definitions and format are same as table 5-6. 
Catalytic 
residue 
Residue 
energy 
Total 
energy #mutations %b-H %b-P %b-T 
13A 
(open) 6.5577 -240.824 19 (1) 84 73.4 82.3 
13B 
(almost 
closed) 
19.6671 -236.83 16 (0) 67.8 65.1 67.3 
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      b. 
 
 
 
 
 
 
 
 
 
Figure 5-11.  KPY rotamer and the HESR benzal rotamer.  a.  new rotamer 
library generated for the testing of GBIAS on KDPG aldolase.  The intermediate 
is the carbinolamine intermediate resulting from lysine and pyruvate.  The new 
rotamer is named KPY.  Arrows indicate the dihedral angle is varied.  KPY is 
similar to the HESR for the benzaldehyde-acetone aldol reaction (b). 
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 a.         b. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 c.   d.   e.         f. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-12.  Using GBIAS to retain crystallographic hydrogen bonds in 
KDPG aldolase.  a.  Stick representation of the interactions of the trapped 
intermediate with surrounding residues. (Figure from Allard et al., PNAS, 2002)26  
b.  A subunit of KDPG aldolase used for design.  Residues surrounding Lys133 
were designed.  c.  Stick representation of the active site residues shown in the 
same orientation as in a.  GBIAS energy=0, no hydrogen bonds retained.  d.  
GBIAS energy=5, 1 hydrogen bond retained.  e.  GBIAS energy=10.  Most 
hydrogen bonds from crystal structure are retained.  f.  Superimposition of the 
designed active site onto wild-type active site.  KPY at 133 superimposes onto 
the trapped intermediate. 
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a.           b. 
 
 
Figure 5-13.  Ribbon diagram of ribose binding protein in open and closed 
conformations.  a.  Open conformation is shown in yellow.  Upon ligand binding, 
(ribose is shown in sticks) the two domains close in the closed conformation 
(magenta).  The open conformation is 43º open compared to the closed form.  b.  
The extensive hydrogen bond network employed to bind ribose in the RBP 
binding site. 
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Figure 5-14.  HESR in the binding pocket of RBP.  a.  HESR is placed in place 
of Arg141. b.  HESR is placed in place of Arg90.  Side chains are shown in sticks 
in CPK-inspired colors.  The dot surface is where ribose binds in the crystal 
structure. 
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      b. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-15.  Modeled active site on RBP for aldol reaction.  a.  HESR is 
shown in cyan.  The phenyl ring of HESR is “caged” in phenyl rings.  It is stacked 
in between the phenyl rings of Phe15 and Phe164, and perpendicular to Phe16.  
b.  The hydroxyl groups on HESR could form hydrogen bonds with Ser105 and 
possibly with Arg90. 
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Figure 5-16.  CD wavelength scan of RBP and mutants.   
KAL: R141K/D215A/Q235L.  VSK: D89V/N105S/R141K.  VSKAL: 
D89V/N105S/R141K/D215A/Q235L.  KAL and VSKAL do not appear to be folded 
correctly.  R141K, VSK have more intense signal than wild-type RBP, with 
minimums at 208nm and 222nm as is characteristic of proteins with mostly 
helices. 
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Figure 5-17.  Catalytic assay of 38C2.  Absorbance at 318nm increased upon 
addition of acetylacetone, in accordance with the formation of the vinylogous 
amide.  Calculation of the actual binding site shows 38C2 to be 73% active. 
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Figure 5-18.  Catalytic assay of RBP and R141K.  This is representative of the 
catalytic assays performed with the remaining mutants of RBP.  No vinylogous 
amide formation is observed. 
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Figure 5-19.  Ribbon diagram of tenth fibronectin type III domain.  The four 
core residues, Y32, W22, I34 and I70 are shown in space filling model.  
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Figure 5-20.  Ribbon diagram of mLTP.  The five residue positions that are 
mutated to lysine are shown in sticks model.  The Nε of the lysines are colored 
blue. 
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        b. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-21.  Circular dichroism spectroscopy of mLTP and mutants.   
a.  Wavelength scans of wild-type (WT) mLTP and the four folded mutants, 18K, 
33K, 49K, and 79K.  The scans show the characteristic minimus at 208nm and 
222nm for helical proteins.  b.  Thermal denaturations of the five proteins.  Of the 
mutants, 18K is most destabilized, with an apparent Tm of 74 °C.  33K: 78 °C.  
49K: 78 °C.  79K: 76 °C. 
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Chapter 6 
 
Double Mutant Cycle Study of 
Cation-π  Interaction 
 
 
 
 
 
 
 
 
 
 
 
 
This work was done in collaboration with Shannon Marshall. 
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 Introduction 
 The marginal stability of a protein is not due to one dominant force, but to 
a balance of many non-covalent interactions between amino acids arising from 
hydrogen bonding, electrostatics, van der Waals interaction, and hydrophobic 
interactions.1  These forces confer secondary and tertiary structure to proteins, 
allowing amino acid polymers to fold into their unique native structures.  Even 
though hydrogen bonding is electrostatic by nature, most would think of 
electrostatics as the nonspecific repulsion between like charges, and the specific 
attraction between oppositely charged side chains, referred to as a salt bridge.  
The cation-π interaction is another type of specific attractive electrostatic 
interaction.  It was experimentally validated to be a strong non-covalent 
interaction in the early 1980s using small molecules in the gas phase.  Evidence 
of cation-π interactions in biological systems was provided by Burley and 
Petsko.2,3  They discovered a prevalence of aromatic-aromatic and amino-
aromatic interactions, and found them to be stabilizing forces. 
Cation-π interactions are defined as the favorable electrostatic interactions 
between a positive charge and the partial negative charge of the quadrupole 
moment of an aromatic ring (Figure 6-1).  In this view, the π system of the 
aromatic side chain contributes partial negative charges above and below the 
plane, forming a permanent quadrupole moment that interacts favorably with the 
positive charge.  The aromatic side chains are viewed as polar, yet hydrophobic 
residues.  Gas phase studies established the interaction energy between K+ and 
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 benzene to be 19 kcal mol-1, even stronger than that of K+ and water.4  In 
aqueous media, the interaction is weaker.   
Evidence strongly indicates this interaction is involved in many biological 
systems where proteins bind cationic ligands or substrates.4  In unliganded 
proteins, the cation-π interaction is typically between a cationic side chain (Lys or 
Arg) and an aromatic side chain (Trp, Phe, or Tyr).   Gallivan and Dougherty5 
used an algorithm based on distance and energy to search through a 
representative dataset of 593 protein crystal structures.  They found that ~21% of 
all interacting pairs involving K, R, F, Y, and W are significant cation-π 
interactions.  Using representative molecules, they also conducted a 
computational study of cation-π interactions vs. salt bridges in aqueous media.  
They found that the well depth of the cation-π interaction was 5.5 kcal mol-1 in 
water compared to 2.2 kcal mol-1 for salt bridges, even though salt bridges are 
much stronger in gas phase studies.  The strength of the cation-π interaction in 
water led them to postulate that cation-π interactions would be found on protein 
surfaces, where they contribute to protein structure and stability.  Indeed, cation-
π pairs are rarely completely buried in proteins.6 
There are six possible cation-π pairs resulting from two cationic side 
chains (K, R) and three aromatic side chains (W, F, Y).  Of the six, the pair with 
the most occurrences is RW, accounting for 40% of the total cation-π interactions 
found in a search of the PDB database.  In the same study, Gallivan and 
Dougherty also found that the most common interaction is between neighboring 
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 residues, with i and (i+4) the second most common.5  This suggests cation-π 
interactions can be found within α-helices.  A geometry study of the interaction 
between R and aromatic side chains showed that the guanidinium group of the R 
side chain stacks directly over the plane of the aromatic ring in a parallel fashion 
more often than would be expected by chance.7  In this configuration, the R side 
chain is anchored to the aromatic ring by the cation-π interaction, but the three 
nitrogen atoms of the guanidinium group are still free to form hydrogen bonds 
with any neighboring residues to further stabilize the protein.   
In this study we seek to experimentally determine the interaction energy 
between a representative cation-π pair, R and W, in positions i and (i+4).  This 
will be done using the double mutant cycle on a variant of the all α-helical protein 
engrailed homeodomain.  The variant is a surface and core designed engrailed 
homeodomain (sc1) that has been extensively characterized by a former Mayo 
group member, Chantal Morgan.8  It exhibits increased thermal stability over the 
wild type.  Since cation-π pairs are rarely found in the core of the protein, we 
chose to place the pair on the surface of our model system.   
 
Materials and Methods 
Computational Modeling   
In order to determine the optimal placement of the cation-π interacting 
pair, the ORBIT (Optimization of Rotamers by Iterative Techniques) suite of 
protein design software developed by the Mayo group was used.  The 
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 coordinates of the 56-residue engrailed homeodomain structure were obtained 
from PDB entry 1enh.  Residues 1-5 are disordered in the absence of DNA, and 
thus were removed from the structure.  The remaining 51 residues were 
renumbered, explicit hydrogens were added using the program BIOGRAF 
(Molecular Simulations, Inc., San Diego, California), and the resulting structure 
was minimized for 50 steps using the DREIDING forcefield.9  The surface-
accessible area was generated using the Connolly algorithm.10  Residues were 
classified as surface, boundary, or core as described.11 
 Engrailed homeodomain is composed of three helices.  We considered 
two sites for the cation-π interaction, residue pairs 9 and 13, and 42 and 46 
(Figure 6-2).  Both pairs are in the middle of their respective α-helix on the 
protein surface.  Discrete rotamers from the Dunbrack and Karplus backbone-
dependent rotamer library12 were used to represent the side-chains.  Rotamers at 
±1 standard deviation about χ1 and χ2 were also included.  Four calculations were 
performed at each site.  For the 9 and 13 pair, R was placed at position 9, W at 
position 13, and the surrounding positions (i-4, i-1, i+1, j-1, j+1, j+4 where i=9 and 
j=13) were mutated to A.  The interaction energy was then calculated.  This 
approach allowed the best conformations of R and W to be chosen for maximal 
cation-π interaction.  Next, the conformations of R and W at positions 9 and 13 
were held fixed, while the conformations of the surrounding residues, but not the 
identity, were allowed to change.  This way, the interaction energy between the 
cation-π pair and the surrounding residues was calculated.  The same 
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 calculations were performed with W at position 9, and R at position 13, and 
likewise for both possibilities at sites 42 and 46.   
The geometry of the cation-π pair was optimized using van der Waals 
interactions scaled by 0.9,13 and electrostatic interactions were calculated using 
Coulomb’s law with a distance-dependent dielectric of 2r.  Partial atomic charges 
from the OPLS force field,14 which reflect the quadropole moment of  aromatic 
groups, were used.  The interaction energies between the cation-π pair and the 
surrounding residues were calculated using the standard ORBIT parameters and 
charge set.15  Pairwise energies were calculated using a force field containing 
van der Waals, Coulombic, hydrogen bond, and polar hydrogen burial penalty 
terms.16  The optimal rotameric conformations were determined using the dead-
end elimination (DEE) theorem with standard parameters.17 
Of the four possible combinations at the two sites chosen, two pairs had 
good interaction energies between the cation-π pair, and with the surrounding 
residues:  W42-R46 and R9-W13.  A visual examination of the resulting models 
showed that R9-W13 exhibited optimal cation-π geometry (Figure 6-3); this pair 
was therefore investigated experimentally using the double-mutant cycle.  
 
Protein Expression and Purification 
For ease of expression and protein stability, sc1, the core- and surface- 
optimized variant of homeodomain was used instead of wild-type homeodomain.  
Four variants of sc1 were made for the double mutant cycle: 9A/13A, 9A/13W, 
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 9R/13A, and 9R/13W.  All variants were generated by site-directed mutagenesis 
using inverse PCR, and the resulting plasmids were transformed into XL1 Blue 
cells (Stratagene) by heat shock.  The cells were grown for approximately 40 
minutes at 37 ºC and plated on agarose containing ampicillin.  The plasmids also 
contained a gene conferring ampicillin resistance, allowing only cells with 
successful transformations to survive.  After overnight growth at 37 ºC, colonies 
were picked and grown in 10 ml LB with ampicillin.  The plasmids were extracted 
from the cells, purified, and verified by DNA sequencing.  Plasmids with correct 
sequences were then transformed into competent BL21 (DE3) cells (Stratagene) 
by heat shock for expression.   
One liter LB with cells for each mutant was grown at 37º C to an OD of 0.6 
at 600 nm.  Cells were then induced with IPTG and grown for 4 hours.  The 
recombinant proteins were isolated from cells using the freeze-thaw method18 
and purified by reverse-phase HPLC.  HPLC was performed using a C8 prep 
column (Zorbax) and linear water-acetonitrile gradients with 0.1% trifluoroacetic 
acid.  The identities of the proteins were checked by MALDI-TOF; all masses 
were within one unit of the expected weight. 
 
Circular Dichroism (CD) 
CD data were collected using an Aviv 62A DS spectropolarimeter 
equipped with a thermoelectric cell holder and an autotitrator.  Urea denaturation 
data was acquired every 0.2 M from 0.0 M to 9.0 M with a 9 minute mixing time 
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 and 100 second averaging time at 25º C.  Samples contained 5 μM protein and 
50 mM sodium phosphate adjusted to pH 4.5.  Protein concentration was 
determined by UV spectrophotometry.  To maintain constant pH, the urea stock 
solution also was adjusted to pH 4.5.  Protein unfolding was monitored at 222 
nm.  Urea concentration was measured by refractometry.  ΔGu was calculated 
assuming a two-state transition and using the linear extrapolation model.19   
 
Double Mutant Cycle Analysis 
The strength of the cation-π interaction was calculated using the following 
equation: 
 ΔGcation-π = (ΔGRW - ΔGAA) - [(ΔGRA - ΔGAA) + (ΔGAW - ΔGAA)] (6-1) 
  ΔGRW = free energy of unfolding of the R9/W13 mutant 
  ΔGAA  = free energy of unfolding of the A9/A13 mutant 
  ΔGRA  =  free energy of unfolding of the R9/A13 mutant 
  ΔGAW =  free energy of unfolding of the A9/W13 mutant 
 
Results and Discussion 
 The urea denaturation transitions of all four homeodomain variants were 
similar, as shown in Figure 6-4 and Table 6-1.  The cation-π interaction energy, 
determined using the double mutant cycle, indicates that it is unfavorable on the 
order of 1.4 kcal mol-1.  However, additional factors must be considered.  First, 
the cooperativity of the transitions, given by the m-value, ranges from 0.73 to 
0.91 kcal mol-1 M-1.  The low m-values suggest that the transitions may not be two 
state.  Therefore, free energies calculated assuming a two-state transition may 
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 not be accurate, affecting the interaction energy calculated from the double 
mutant cycle.20  Second, the urea denaturation curves for all four variants lack a 
well-defined post-transition, which makes fitting of the experimental data to a two-
state model difficult.   
 In addition to low cooperativity, analysis of the surrounding residues of Arg 
and Trp provided further insight.  In the sc1 variant, the (i-4, i-1, i+1, j-1, j+1, and 
j+4) residues are E, K, R, E, E, and R, respectively.  R9 and W13 are in a very 
charged environment.  In the R9/W13 variant, the cation-π interaction is in conflict 
with the local interactions that R9 and W13 can form with E5 and R17.  The 
double mutant cycle is not appropriate for determining an isolated interaction in a 
charged environment.  The charged residues surrounding R9 and W13 need to 
be mutated to provide a neutral environment.   
 The cation-π interaction introduced to homeodomain mutant sc1 does not 
contribute to protein stability.  Several improvements can be made for future 
studies.  First, since sc1 is the experimental system, the sc1 sequence should be 
used in the modeling studies.  Second, to achieve a well-defined post-transition, 
urea denaturations could be performed at a higher temperature.  pH of protein 
could be adjusted to 7.0 instead of 4.5.  Because sc1 is a stable protein, perhaps 
the 9 minute mixing time with denaturant is not long enough to reach equilibrium.  
Longer mixing times could be tried.  Third, the immediate surrounding residues of 
the cation-π pair can be mutated to Ala to provide a neutral environment to 
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 isolate the interaction.  This way, the interaction energy of a cation-π pair can be 
accurately determined. 
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Figure 6-1  Schematic of the cation-π interaction.   
Left:  a generic cation is shown positioned along a benzene ring.  Right: space-
filling model of the K+···benzene complex; the optimal geometry has the cation 
interacting with the face of the aromatic ring, not the edge.  Adapted from Ma & 
Dougherty, 1997.4 
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Figure 6-2  Ribbon diagram of engrailed homeodomain.  
The tertiary structure of engrailed homeodomain, with positions 9, 13, 42, and 46 
labeled.  Side-chains shown are wild type. 
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Figure 6-3  Modelled Arg9-Trp13 in engrailed homeodomain.  
a. Modelled Arg9-Trp13 pair with planar stacking of the guanidinium group of Arg 
with the aromatic ring of Trp.  b. The two groups are in close van der Waals 
contact, which should allow optimal cation-π contact. 
 
 
 
 
 
a b 
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Figure 6-4  Urea denaturation of homeodomain variants.   
Urea denaturation of homeodomain variants for double mutant cycle analysis.  
A9/A13 is shown in red, R9/A13 in blue, A9/W13 in green, and R9/W13 in 
orange. 
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Table 6-1:  Thermodynamic parameters of homeodomain 
variants from urea denaturation.20 
 ΔGua (kcal mol-1) Cmb (M) Mc (kcal mol-1 M-1) 
AA 4.82 6.6 0.73 
AW 5.99 6.6 0.91 
RA 5.58 6.6 0.85 
RW 5.36 6.4 0.84 
aFree energy of unfolding at 25 ºC 
bMidpoint of the unfolding transition 
cSlope of ΔGu versus denaturant concentration 
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Chapter 7 
 
Modulating nAChR Agonist Specificity by  
Computational Protein Design 
 
 
 
 
 
 
 
 
 
 
 
The text of this chapter and work described were done in collaboration with 
Amanda L. Cashin. 
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Introduction 
Ligand gated ion channels (LGIC) are transmembrane proteins involved in 
biological signaling pathways.  These receptors are important in Alzheimer’s, 
Schizophrenia, drug addiction and learning and memory.1  Small molecule 
neurotransmitters bind to these transmembrane proteins, induce a 
conformational change in the receptor, and allow the protein to pass ions across 
the impermeable cell membrane.  A number of studies have identified key 
interactions that lead to binding of small molecules at the agonist binding site of 
LGICs.  High-resolution structural data on neuroreceptors are only just becoming 
available,2-4 and functional data are still needed to further understand the binding 
and subsequent conformational changes that occur during channel gating. 
Nicotinic acetylcholine receptors (nAChR) are one of the most extensively 
studied members of the Cys-loop family of LGICs, which include γ-aminobutyric, 
glycine and serotonin receptors.  The embryonic mouse muscle nAChR is a 
transmembrane protein composed of five subunits, (α1)2βγδ.5  Biochemical 
studies 6,7 and the crystal structure of the acetylcholine binding protein (AChBP),2 
a soluble protein highly homologous to the ligand binding domain of the nAChR 
(Figure 7-1), identified two agonist binding sites at the α/γ and α/δ interfaces on 
the muscle type nAChR that are defined by an aromatic box of conserved amino 
acid residues.  The principal face of the agonist binding site contains four of the 
five conserved aromatic box residues, while the complementary face contains the 
remaining aromatic residue.    
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Structurally similar nAChR agonists acetylcholine (ACh), nicotine (Nic) and 
epibatidine (Figure 7-2) bind to the same aromatic binding site with differing 
activity.  Recently, Sixma and co-workers published a nicotine bound crystal 
structure of AChBP3 which reveals additional agonist binding determinants.  To 
verify the functional importance of potential agonist-receptor interactions revealed 
by the AChBP structures, chemical scale investigations were performed to 
identify mechanistically significant drug-receptor interactions at the muscle-type 
nAChR.8,9  These studies identified subtle differences in the binding determinants 
that differentiate ACh, Nic and epibatidine activity.   
Interestingly, these three agonists also display different relative activity 
among different nAChR subtypes.  For example, the neuronal α7 nAChR subtype 
displays the following order of agonist potency:  epibatidine > nicotine >ACh.10  
For the mouse muscle subtype the following order of agonist potency is 
observed:  epibatidine >  ACh >> nicotine.8,11    A better understanding of residue 
positions that play a role in agonist specificity would provide insight into the 
conformational changes that are induced upon agonist binding.  This information 
could also aid in designing nAChR subtype specific drugs. 
The present study probes the residue positions that affect nAChR agonist 
specificity for acetylcholine, nicotine, and epibatidine.  To accomplish this goal, 
we utilized AChBP as a model system for computational protein design studies to 
improve the poor specificity of nicotine at the muscle type nAChR.   
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Computational protein design is a powerful tool for the modification of 
protein-protein,12 protein-peptide,13 protein-ligand14 interactions.  For example, a 
designed calmodulin with 13 mutations from the wild-type protein showed a 155-
fold increase in binding specificity for a peptide.13  In addition, Looger et al. 
engineered proteins from the periplasmic binding protein superfamily to bind 
trinitrotoluene at nanomolar affinity, and lactate and serotonin at micromolar 
affinity.14  These studies demonstrate the ability of computational protein design 
to successfully predict mutations that dramatically affect binding specificity of 
proteins.   
With the availability of the 2.2 Å crystal structure of AChBP-nicotine 
complex,3 the present study predicted mutations in efforts to stabilize AChBP in 
the nicotine preferred conformation by computational protein design.  AChBP, 
although not a functional full-length ion-channel, provides a highly homologous 
model system to the extracellular ligand binding domain of nAChRs.  The present 
study utilizes mouse muscle nAChR as the functional receptor to experimentally 
test the computational predictions.  By stabilizing AChBP in the nicotine-bound 
conformation, we aim to modulate the binding specificity of the highly 
homologous muscle type nAChR for three agonists nicotine, acetylcholine and 
epibatidine. 
 
Materials and Methods 
Computational Protein Design with ORBIT 
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The AChBP-nicotine structure (PDB ID 1UWA) was obtained from the 
Protein Data Bank.3  The subunits forming the binding site at the interface of B 
and C were selected for our design while the remaining three subunits (A, D, E) 
and the water molecules were deleted.  Hydrogens were added with the Reduce 
program of MolProbity (http://kinemage.biochem.duke.edu/molprobity) and 
minimized briefly with ORBIT.  The ORBIT protein design suite uses a physically 
based force-field and combinatorial optimization algorithms to determine the 
optimal amino acid sequence for a protein structure.15,16  A backbone dependent 
rotamer library with χ1 and χ2 angles expanded by ±15° around all residues 
except Arg and Lys was used.17  Charges for nicotine were calculated ab initio 
with Jaguar (Shrodinger) using density field theory with the exchange-correlation 
hybrid B3LYP and 6-31G** basis set.  Nine residues (chain B: 89, 143, 144, 185, 
192.  chain C: 104, 112, 114, 53) interacting directly with nicotine are considered 
the primary shell, and were allowed to be all amino acids except Gly.  Residues 
contacting the primary shell residues are considered the secondary shell (chain 
B: 87, 139, 141, 142, 146, 149, 182, 183, 184.  chain C: 33, 34, 36, 51, 55, 57, 
75, 98, 99, 102, 106, 110, 113, 116).  Wild-type prolines and glycines were not 
designed.  87B, 33C and 113C were allowd to be all nonpolar amino acids except 
methionine, and 144B, 146B, 182B, 34C, 57C, 75C and 116C were allowed to be 
all polar residues.  A tertiary shell includes residues within 4 Å of primary and 
secondary shell residues, and they were allowed to change in amino acid 
conformation but not identity.  A bias towards the wild-type sequence using the 
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SBIAS module was applied at 1, 2, and 4 kcal*mol-1.  An algorithm based on the 
dead end elimination theorem (DEE) was used to obtain the global minimum 
energy amino acid sequence and conformation (GMEC).18  
 
Mutagenesis and Channel Expression  
In vitro runoff transcription using the AMbion mMagic mMessage kit was 
used to prepare mRNA.  Site-directed mutagenesis was performed using Quick-
Change mutagenesis and was verified by sequencing.  For nAChR expression, a 
total of 4.0 ng of mRNA was injected in the subunit ration of 2:1:1:1 α:β:γ:δ.  The 
β subunit contained a L9'S mutation, as discussed below.  Mouse muscle 
embryonic nAChR in the pAMV vector was used, as reported previously. 
 
Electrophysiology 
Stage VI oocytes of Xenopus laevis were harvested according to approved 
procedures. Oocyte recordings were made 24 to 48 h post-injection in two-
electrode voltage clamp mode using the OpusXpressTM 600A (Molecular Devices 
Corporation, Union City, California).8,19  Oocytes were superfused with calcium-
free ND96 solution at flow rates of 1ml/min, 4 ml/min during drug application and 
3 ml/min wash.  Cells were voltage clamped at –60 mV.  Data were sampled at 
125 Hz and filtered at 50 Hz.  Drug applications were 15 s in duration.  Agonists 
were purchased from Sigma/Aldrich/RBI:  9([-]-nicotine tartrate), (acetylcholine 
chloride) and ([±] epibatidine).  Epibatidine was also purchased from Tocris ([±] 
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epibatidine).  All drugs were prepared in calcium-free ND96.  Dose-response 
data were obtained for a minimum of 10 concentrations of agonists and for a 
minimum of 4 different cells.  Curves were fitted to the Hill equation to determine 
EC50 and Hill coefficient.   
 
Results and Discussion 
Computational Design 
 The design of AChBP in the nicotine bound state predicted 10 mutations. 
To identify those predicted mutations that contribute the most to the stabilization 
of the structure, we used the SBIAS module of ORBIT, which applies a bias 
energy toward wild-type residues. We identified two predicted mutations, T57R 
and S116Q (AChBP numbering will be used unless otherwise stated) in the 
secondary shell of residues, with strong interaction energies.  They are on the 
complementary subunit of the binding pocket (chain C) and formed inter-subunit 
side chain to backbone hydrogen bonds to the primary shell residues (Figure 7-
3).  S116Q reaches across the interface to form a hydrogen bond with a donor to 
acceptor distance of 3.0 Å with the backbone oxygen of Y89, one of the aromatic 
box residues important in forming the binding pocket.  T57R makes a network of 
hydrogen bonds.  E110 flips from the crystallographic conformation to form a 
hydrogen bond with a donor to acceptor distance of 3.0 Å with T57R, which also 
hydrogen bonds with E157 in its crystallographic conformation.  T57R could also 
form a potential hydrogen bond, with a donor to acceptor distance of 3.6 Å, to the 
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backbone oxygen of C187, part of a disulfide cysteine bond on a principal loop in 
the binding domain.  Most of the nine primary shell residues kept the 
crystallographic conformations, a testament to the high affinity of AChBP for 
nicotine (Kd=45nM).3  
 Interestingly, T57 is naturally R in AChBP from Aplysia californica, a 
different species of snail.  It is not a conserved residue.  From the sequence 
alignment (Figure 7-1) residue 57 is Q, E, Q, A in the alpha, beta, gamma, and 
delta subunits respectively.  In addition, the S116Q mutation is at a highly 
conserved position in nAChRs.  In all four mouse muscle nAChR subunits, 
residue 116 is a proline, part of a PP sequence.  The mutation study will give us 
important insight into the necessity of the PP sequence for the function of 
nAChRs. 
 
Mutagenesis 
Conventional mutagenesis for T57R was performed at the equivalent 
position of AChBP’s complementary face on the mouse muscle nAChR at γQ59R 
and δA61R subunits.  The mutant receptor was evaluated using 
electrophysiology.  When studying weak agonists and/or receptors with 
diminished binding capability, it is necessary to introduce a Leu-to-Ser mutation 
at a site known as 9' in the second transmembrane region of the β subunit.8,9  
This 9’ site in the β subunit is almost 50 Å from the binding site, and previous 
work has shown that a L9'S mutation lowers the effective concentration at half 
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maximal response (EC50) by a factor of roughly 10.9,20    Results from earlier 
studies9,20 and data reported below demonstrate that trends in EC50 values are 
not perturbed by L9'S mutations.  In addition, the alpha subunits contain an HA 
epitope between M3 and M4.  Control experiments show a negligible effect of this 
epitope on EC50.  Measurements of EC50 represent a functional assay; all mutant 
receptors reported here are fully functioning ligand-gated ion channels.  It should 
be noted that the EC50 value is not a binding constant, but a composite of 
equilibria for both binding and gating.  
 
Nicotine Specificity Enhanced by 59R Mutation 
The ability of the γ59Rδ61R mutant to impact nicotine specificity at the 
muscle type nAChR was tested by determining the EC50 in the presence of 
acetylcholine, nicotine and epibatidine (Figure 7-4).  The EC50 values for the wild-
type and mutant receptors are show in Table 7-1.  The computational design 
studies predict this mutation will help stabilize the nicotine bound conformation by 
enabling a network of hydrogen bonds with side chains of E110 and E157 as well 
as the backbone carbonyl oxygen of C187.   
Upon mutation, the EC50 of nicotine decreases 1.8-fold compared to the 
wild-type value, thus improving the potency of nicotine for the muscle-type 
nAChR.  Conversely, ACh shows 3.9-fold increase in EC50 compared to the wild-
type value, thus decreasing the potency of ACh for the nAChR.  The values for 
epibatidine are relatively unchanged in the presence of the mutation in 
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comparison to wild-type.  Interestingly, these data show a change in agonist 
specificity of ACh and epibatidine in comparison to nicotine for the nAChR.  The 
wild-type receptor prefers ACh 69-fold more than nicotine and epibatidine 95-fold 
more than nicotine.  The agonist specificity is significantly changed with the 
γ59Rδ61R mutant where the receptor’s preference for ACh decreases to 10-fold 
over nicotine and epibatidine decreases to 44-fold over nicotine.  The specificity 
change can be quantified in the ΔΔG values from Table 7-1.  These values 
indicate a more favorable interaction for nicotine (-0.3 kcal/mol) than for ACh (0.8 
kcal/mol) and epibatidine (0.1 kcal/mol) in the presence of the γ59Rδ61R mutant 
compared to wild-type receptors.    
The ability of this single mutation to enhance nicotine specificity of the 
mouse nAChR demonstrates the importance of the secondary shell residues 
surrounding the agonist binding site in determining agonist specificity.  Because 
the aromatic box is nearly 100% conserved among nAChRs, we hypothesize the 
agonist specificity does not depend on the amino acid composition of the binding 
site itself, but on specific conformations of the aromatic residues.  It is possible 
that the secondary shell residues, significantly less conserved among nAChR 
sub-types, play a role in stabilizing unique agonist preferred conformations of the 
binding site.  The T57R mutation, a secondary shell residue on the 
complementary face of the binding domain, was designed to interact with the 
primary face shell residue C187 across the subunit interface to stabilize the 
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nicotine preferred conformation.  These data demonstrate the importance of this 
secondary shell residue in determining agonist activity and selectivity. 
Because the nicotine bound conformation was used as the basis for the 
computational design calculations, the design generated mutations that would 
further stabilize the nicotine bound state.  The 57R mutation electrophysiology 
data demonstrate an increase in preference in nicotine for the receptor compared 
to wild-type receptors.  The activity of ACh, structurally different from nicotine, 
decreases possibly because it undergoes an energetic penalty to reorganize the 
binding site into an ACh preferred conformation or to bind to a nicotine preferred 
confirmation.  The changes in ACh and nicotine preference for the designed 
binding pocket conformation leads to a 6.9-fold increase in specificity for nicotine 
in the presence of 57R.  The activity of epibatidine, structurally similar to nicotine, 
remains relatively unchanged in the presence of the 57R mutation.  Perhaps the 
binding site conformation of epibatidine more closely resembles that of nicotine 
and therefore does not undergo a significant change in activity in the presence of 
the mutation.  Therefore only a 2.2-fold increase in agonist specificity is observed 
for nicotine over epibatidine.    
 
Conclusions and Future Directions    
The present study aimed to utilize computational protein design to 
modulate the agonist specificity of nAChR for nicotine, acetylcholine and 
epibatidine. By stabilizing nAChR in the nicotine-bound conformation, we 
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predicted two mutations to stabilize the nAChR in the nicotine preferred 
conformation.  The initial data has corroborated our design.  The T57R mutation 
is responsible for a 6.9-fold increase in specificity of nicotine over acetylcholine, 
and 2.2-fold increase for nicotine over epibatidine.  The S116Q mutations 
experiments are currently underway.  Future directions could include probing 
agonist specificity of these mutations at different nAChR subtypes and other Cys-
loop family members.  As future crystallographic data become available this 
method could be extended to investigate other ligand-bound LGIC binding sites.     
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 AChBP-L        LDRADILYN-IRQTSR----PDVIPTQRDR-PVAVSVSLKFINILEVNEITNEVDVVFWQ 
AChBP-A        --QANLMRLKSDLFNR----SPMYPGPTKDDPLTVTLGFTLQDIVKVDSSTNEVDLVYYE 
alpha-m        LGSEHETRLVAKLFED--YSSVVRPVEDHREIVQVTVGLQLIQLINVDEVNQIVTTNVRL 
beta-m         RGSEAEGQLIKKLFSN--YDSSVRPAREVGDRVGVSIGLTLAQLISLNEKDEEMSTKVYL 
gamma-m        QSRNQEERLLADLMRN--YDPHLRPAERDSDVVNVSLKLTLTNLISLNEREEALTTNVWI 
delta-m        WGLNEEQRLIQHLFNEKGYDKDLRPVARKEDKVDVALSLTLSNLISLKEVEETLTTNVWI 
 
 
AChBP-L        QTTWSDRTLAWNSSHSP--DQVSVPISSLWVPDLAAYNAISKPEVLTPQLARVVS-DGEV 
AChBP-A        QQRWKLNSLMWDPNEYGNITDFRTSAADIWTPDITAYSSTRPVQVLSPQIAVVTH-DGSV 
alpha-m        KQQWVDYNLKWNPDDYGGVKKIHIPSEKIWRPDVVLYNNADGDFAIVKFTKVLLDYTGHI 
beta-m         DLEWTDYRLSWDPAEHDGIDSLRITAESVWLPDVVLLNNNDGNFDVALDINVVVSFEGSV 
gamma-m        EMQWCDYRLRWDPKDYEGLWILRVPSTMVWRPDIVLENNVDGVFEVALYCNVLVSPDGCI 
delta-m        DHAWVDSRLQWDANDFGNITVLRLPPDMVWLPEIVLENNNDGSFQISYACNVLVYDSGYV 
 
 
AChBP-L        LYMPSIRQRFSCDVSGVDTESG-ATCRIKIGSWTHHSREISVDPTTEN-----------S 
AChBP-A        MFIPAQRLSFMCDPTGVDSEEG-VTCAVKFGSWVYSGFEIDLKTDTDQ-----------V 
alpha-m        TWTPPAIFKSYCEIIVTHFPFDEQNCSMKLGTWTYDGSVVAINPESDQ--------P--D 
beta-m         RWQPPGLYRSSCSIQVTYFPFDWQNCTMVFSSYSYDSSEVSLKTGLDPE---GEERQEVY 
gamma-m        YWLPPAIFRSSCSISVTYFPFDWQNCSLIFQSQTYSTSEINLQLSQED----GQAIEWIF 
delta-m        TWLPPAIFRSSCPISVTYFPFDWQNCSLKFSSLKYTAKEITLSLKQEEENNRSYPIEWII 
 
 
AChBP-L        DDSEYFSQYSRFEILDVTQKKNSVTYSC--C-PEAYEDVEVSLNFRKKGRSEIL------ 
AChBP-A        DLSSYYAS-SKYEILSATQTRQVQHYSC--C-PEPYIDVNLVVKFRERRAGNGFFRNLFD 
alpha-m        LSN--FMESGEWVIKEARGWKHWVFYSC--CPTTPYLDITYHFVMQRLPLYFIVNVIIPC 
beta-m         IHEGTFIENGQWEIIHKPSRLIQLPGDQRGGKEGHHEEVIFYLIIRRKPLFYLVNVIAPC 
gamma-m        IDPEAFTENGEWAIRHRPAKMLLDSVAP--AEEAGHQKVVFYLLIQRKPLFYVINIIAPC 
delta-m        IDPEGFTENGEWEIVHRAAKLNVDPSVP--MDSTNHQDVTFYLIIRRKPLFYIINILVPC 
 
 
Figure 7-1.  Sequence alignment of AChBP with nAChR subunits from 
mouse muscle.  AChBP-L (AChBP Lymnaea) and AChBP-A (AChBP Aplysia) 
are soluble proteins that bind acetylcholine.  The predicted mutations are from 
design calculations on AChBP-L and nicotine complex.  The binding pockets on 
nAChR on mouse muscle are formed between the principle subunit, alpha, and 
complementary subunits, beta, gamma and delta.  The highly conserved 
aromatic box residues are highlighted in magenta, and the residue positions of 
the predicted mutations are in cyan. 
 
 
158
 
 
 
 
 
 
Acetylcholine          Nicotine    Epibatidine 
 
 
Figure 7-2.  Structures of nAChR agonists, acetylcholine, nicotine, and 
epibatidine.  Epibatidine is a nicotine-like agonist. 
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Figure 7-3.  Predicted mutations from computational design of AChBP.  a.  
Ribbon diagram of two AChBP subunits.  Yellow: principle subunit.  Blue: 
complementary subunit.  Nicotine, the predicted mutations, and interacting 
sidechains are shown in CPK-inspired colors.  Nicotine: magenta.  Predicted 
mutations: green in space-filling model.  Interacting residues: cyan.  
Crystallographic conformations are shown in red.  b.  Close-up view of T57R 
interactions.  c.  Close-up view of S116Q .  Hydrogen bonds are shown as black 
dashed lines. 
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Figure 7-4.  Electrophysiology data.  Electropysiological analysis of ACh and 
nicotine.  a.  Representative voltage clamp current traces for oocytes expressing 
mutant muscle nAChRs (α1)β9’γ59Rδ61R.  Bars represent application of ACh and 
nicotine at the concentrations noted.  b.  Representative ACh (  )and nicotine (  ) 
dose-response relations and fits to the Hill equation for oocytes expressing 
(α1)β9’γ59Rδ61R nAChRs. 
 
a. 
b. 
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 Table 7-1.  Mutation enhancing nicotine specificity 
Agonist 
Wild-type 
EC50a 
γ59Rδ61R 
EC50a 
Wild-type 
Nic/Agonist 
γ59Rδ61R 
Nic/Agonist 
γ59Rδ61R 
ΔΔGb 
ACh 0.83 ± 0.04 3.2 ± 0.4 69 10 0.8 
Nicotine 57 ±  2 32 ± 3 1 1 -0.3 
Epibatidine 0.60 ± 0.04 0.72 ± 0.05 95 44 0.1 
aEC50 (µM) ± standard error of the mean.  (-) Nicotine nicotine and racemic 
epibatidine were used in these experiments.    The receptor has a Leu9’Ser 
mutation in M2 of the β subunit.  bΔΔG (kcal/mol). 
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